| Year |
Citation |
Score |
| 2024 |
Ferschmann C, Messerschmidt K, Gnörich J, Barthel H, Marek K, Palleis C, Katzdobler S, Stockbauer A, Fietzek U, Finze A, Biechele G, Rumpf JJ, Saur D, Schroeter ML, Rullmann M, ... ... Bartenstein P, et al. Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies. European Journal of Nuclear Medicine and Molecular Imaging. PMID 38366196 DOI: 10.1007/s00259-024-06637-6 |
0.31 |
|
| 2024 |
Gold L, Barci E, Brendel M, Orth M, Cheng J, Kirchleitner SV, Bartos LM, Pötter D, Kirchner MA, Unterrainer LM, Kaiser L, Ziegler S, Weidner L, Riemenschneider MJ, Unterrainer M, ... ... Bartenstein P, et al. The Traumatic Inoculation Process Affects TSPO Radioligand Uptake in Experimental Orthotopic Glioblastoma. Biomedicines. 12. PMID 38255293 DOI: 10.3390/biomedicines12010188 |
0.786 |
|
| 2024 |
Ruch F, Gnörich J, Wind K, Köhler M, Zatcepin A, Wiedemann T, Gildehaus FJ, Lindner S, Boening G, von Ungern-Sternberg B, Beyer L, Herms J, Bartenstein P, Brendel M, Eckenweber F. Validity and value of metabolic connectivity in mouse models of β-amyloid and tauopathy. Neuroimage. 286: 120513. PMID 38191101 DOI: 10.1016/j.neuroimage.2024.120513 |
0.578 |
|
| 2023 |
Palleis C, Franzmeier N, Weidinger E, Bernhardt AM, Katzdobler S, Wall S, Ferschmann C, Harris S, Schmitt J, Schuster S, Gnörich J, Finze A, Biechele G, Lindner S, Albert NL, ... Bartenstein P, et al. Association of Neurofilament Light Chain, [F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS. Neurology. 102: e207901. PMID 38165362 DOI: 10.1212/WNL.0000000000207901 |
0.745 |
|
| 2023 |
Gower-Fry L, Wängler C, Bartenstein P, Beyer L, Lindner S, Jurkschat K, Wängler B, Bailey JJ, Schirrmacher R. Silicon-Fluoride Acceptors (SiFA) for F-Radiolabeling: From Bench to Bedside. Methods in Molecular Biology (Clifton, N.J.). 2729: 29-43. PMID 38006489 DOI: 10.1007/978-1-0716-3499-8_3 |
0.378 |
|
| 2023 |
Bui VN, Unterrainer LM, Brendel M, Kunte SC, Holzgreve A, Allmendinger F, Bartenstein P, Klauschen F, Unterrainer M, Staehler M, Ledderose S. PSMA-Expression Is Highly Associated with Histological Subtypes of Renal Cell Carcinoma: Potential Implications for Theranostic Approaches. Biomedicines. 11. PMID 38002095 DOI: 10.3390/biomedicines11113095 |
0.474 |
|
| 2023 |
Stockbauer A, Beyer L, Huber M, Kreuzer A, Palleis C, Katzdobler S, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, ... ... Bartenstein P, et al. Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37971501 DOI: 10.1007/s00259-023-06493-w |
0.547 |
|
| 2023 |
Bartos LM, Kirchleitner SV, Kolabas ZI, Quach S, Beck A, Lorenz J, Blobner J, Mueller SA, Ulukaya S, Hoeher L, Horvath I, Wind-Mark K, Holzgreve A, Ruf VC, Gold L, ... ... Bartenstein P, et al. Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution. Science Advances. 9: eadi8986. PMID 37889970 DOI: 10.1126/sciadv.adi8986 |
0.71 |
|
| 2023 |
Blok S, Wängler C, Bartenstein P, Jurkschat K, Schirrmacher R, Lindner S. Good practices for the automated production of F-SiFA radiopharmaceuticals. Ejnmmi Radiopharmacy and Chemistry. 8: 25. PMID 37819534 DOI: 10.1186/s41181-023-00215-1 |
0.386 |
|
| 2023 |
Weidner L, Lorenz J, Quach S, Braun FK, Rothhammer-Hampl T, Ammer LM, Vollmann-Zwerenz A, Bartos LM, Dekorsy FJ, Holzgreve A, Kirchleitner SV, Thon N, Greve T, Ruf V, Herms J, ... ... Bartenstein P, et al. Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages. Acta Neuropathologica Communications. 11: 147. PMID 37697350 DOI: 10.1186/s40478-023-01651-5 |
0.757 |
|
| 2023 |
Unterrainer M, Kunte SC, Unterrainer LM, Holzgreve A, Delker A, Lindner S, Beyer L, Brendel M, Kunz WG, Winkelmann M, Cyran CC, Ricke J, Jurkschat K, Wängler C, Wängler B, ... ... Bartenstein P, et al. Correction to: Next‑generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR‑targeting peptide [F]SiTATE. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37642707 DOI: 10.1007/s00259-023-06409-8 |
0.789 |
|
| 2023 |
Grawe F, Blom F, Winkelmann M, Burgard C, Schmid-Tannwald C, Unterrainer LM, Sheikh GT, Pfitzinger PL, Kazmierczak P, Cyran CC, Ricke J, Stief CG, Bartenstein P, Ruebenthaler J, Fabritius MP, et al. Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients. European Radiology. PMID 37624414 DOI: 10.1007/s00330-023-10083-7 |
0.302 |
|
| 2023 |
Zacherl MJ, Simenhandra A, Lindner M, Bartenstein P, Todica A, Boening G, Fischer M. The assessment of left ventricular volume and function in gated small animal F-FDG PET/CT imaging: a comparative study of three commercially available software tools. Ejnmmi Research. 13: 75. PMID 37572238 DOI: 10.1186/s13550-023-01026-w |
0.392 |
|
| 2023 |
Vogler L, Ballweg A, Bohr B, Briel N, Wind K, Antons M, Kunze LH, Gnörich J, Lindner S, Gildehaus FJ, Baumann K, Bartenstein P, Boening G, Ziegler SI, Levin J, et al. Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [F]UCB-H PET imaging. Neuroimage. Clinical. 39: 103484. PMID 37541098 DOI: 10.1016/j.nicl.2023.103484 |
0.639 |
|
| 2023 |
Albert NL, Nelwan DV, Fleischmann DF, Quach S, von Rohr K, Kaiser L, Teske N, Unterrainer LM, Bartos LM, Ruf VC, Brendel M, Riemenschneider MJ, Wetzel C, Herms J, Rupprecht R, ... ... Bartenstein P, et al. Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH-Wild-Type Glioblastoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37536737 DOI: 10.2967/jnumed.122.265247 |
0.787 |
|
| 2023 |
Palumbo G, Kunze LH, Oos R, Wind-Mark K, Lindner S, von Ungern-Sternberg B, Bartenstein P, Ziegler S, Brendel M. Longitudinal Studies on Alzheimer Disease Mouse Models with Multiple Tracer PET/CT: Application of Reduction and Refinement Principles in Daily Practice to Safeguard Animal Welfare during Progressive Aging. Animals : An Open Access Journal From Mdpi. 13. PMID 37531139 DOI: 10.3390/ani13111812 |
0.58 |
|
| 2023 |
Finze A, Biechele G, Rauchmann BS, Franzmeier N, Palleis C, Katzdobler S, Weidinger E, Guersel S, Schuster S, Harris S, Schmitt J, Beyer L, Gnörich J, Lindner S, Albert NL, ... ... Bartenstein P, et al. Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies. Molecular Psychiatry. PMID 37495886 DOI: 10.1038/s41380-023-02188-8 |
0.65 |
|
| 2023 |
Holzgreve A, Unterrainer M, Calais J, Adams T, Oprea-Lager DE, Goffin K, Lopci E, Unterrainer LM, Kramer KKM, Schmidt-Hegemann NS, Casuscelli J, Stief CG, Ricke J, Bartenstein P, Kunz WG, et al. Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37428216 DOI: 10.1007/s00259-023-06332-y |
0.321 |
|
| 2023 |
Kunze LH, Ruch F, Biechele G, Eckenweber F, Wind-Mark K, Dinkel L, Feyen P, Bartenstein P, Ziegler S, Paeger L, Tahirovic S, Herms J, Brendel M. Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice. International Journal of Molecular Sciences. 24. PMID 37373253 DOI: 10.3390/ijms241210106 |
0.552 |
|
| 2023 |
Unterrainer M, Kunte SC, Unterrainer LM, Holzgreve A, Delker A, Lindner S, Beyer L, Brendel M, Kunz WG, Winkelmann M, Cyran CC, Ricke J, Jurkschat K, Wängler C, Wängler B, ... ... Bartenstein P, et al. Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [F]SiTATE. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37358620 DOI: 10.1007/s00259-023-06315-z |
0.802 |
|
| 2023 |
Menevse AN, Ammer LM, Vollmann-Zwerenz A, Kupczyk M, Lorenz J, Weidner L, Hussein A, Sax J, Mühlbauer J, Heuschneider N, Rohrmus C, Mai LS, Jachnik B, Stamova S, Volpin V, ... ... Bartenstein P, et al. TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma. Acta Neuropathologica Communications. 11: 75. PMID 37158962 DOI: 10.1186/s40478-023-01550-9 |
0.602 |
|
| 2023 |
Holzgreve A, Taugner J, Käsmann L, Müller P, Tufman A, Reinmuth N, Li M, Winkelmann M, Unterrainer LM, Nieto AE, Bartenstein P, Kunz WG, Ricke J, Belka C, Eze C, et al. Metabolic patterns on [F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36951991 DOI: 10.1007/s00259-023-06192-6 |
0.396 |
|
| 2023 |
Ballweg A, Klaus C, Vogler L, Katzdobler S, Wind K, Zatcepin A, Ziegler SI, Secgin B, Eckenweber F, Bohr B, Bernhardt A, Fietzek U, Rauchmann BS, Stoecklein S, Quach S, ... ... Bartenstein P, et al. [F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data. Journal of Neuroinflammation. 20: 68. PMID 36906584 DOI: 10.1186/s12974-023-02749-2 |
0.744 |
|
| 2023 |
Fleischmann DF, Büttner M, Unterrainer M, Corradini S, Zollner B, Hofmaier J, Bodensohn R, Thon N, Belka C, Bartenstein P, Albert NL, Niyazi M. High-Grade Glioma Radiation Therapy and Reirradiation Treatment Planning Using Translocator Protein Positron Emission Tomography With F-GE-180. Advances in Radiation Oncology. 8: 101185. PMID 36896209 DOI: 10.1016/j.adro.2023.101185 |
0.661 |
|
| 2023 |
Gnörich J, Reifschneider A, Wind K, Zatcepin A, Kunte ST, Beumers P, Bartos LM, Wiedemann T, Grosch M, Xiang X, Fard MK, Ruch F, Werner G, Koehler M, Slemann L, ... ... Bartenstein P, et al. Depletion and activation of microglia impact metabolic connectivity of the mouse brain. Journal of Neuroinflammation. 20: 47. PMID 36829182 DOI: 10.1186/s12974-023-02735-8 |
0.672 |
|
| 2023 |
Eschbach RS, Hofmann M, Späth L, Sheikh GT, Delker A, Lindner S, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Tiling R, Brendel M, Wenter V, Dekorsy FJ, Zacherl MJ, ... ... Bartenstein P, et al. Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [F]SiTATE. Frontiers in Oncology. 13: 992316. PMID 36793617 DOI: 10.3389/fonc.2023.992316 |
0.658 |
|
| 2023 |
Trapp C, Oliinyk D, Rogowski P, Von Bestenbostel R, Ganswindt U, Li M, Eze C, Bartenstein P, Beyer L, Ilhan H, Sheikh G, Unterrainer L, Stief C, Westhofen T, Kunz WG, et al. An analysis of PSMA-PET/CT-positive lymph node distribution and their coverage by different elective nodal radiation volumes in postoperative prostate cancer patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 36732055 DOI: 10.2967/jnumed.122.265159 |
0.323 |
|
| 2023 |
Zounek AJ, Albert NL, Holzgreve A, Unterrainer M, Brosch-Lenz J, Lindner S, Bollenbacher A, Boening G, Rupprecht R, Brendel M, von Baumgarten L, Tonn JC, Bartenstein P, Ziegler S, Kaiser L. Feasibility of radiomic feature harmonization for pooling of [F]FET or [F]GE-180 PET images of gliomas. Zeitschrift Fur Medizinische Physik. PMID 36710156 DOI: 10.1016/j.zemedi.2022.12.005 |
0.772 |
|
| 2023 |
Zatcepin A, Kopczak A, Holzgreve A, Hein S, Schindler A, Duering M, Kaiser L, Lindner S, Schidlowski M, Bartenstein P, Albert N, Brendel M, Ziegler SI. Machine learning-based approach reveals essential features for simplified TSPO PET quantification in ischemic stroke patients. Zeitschrift Fur Medizinische Physik. PMID 36682921 DOI: 10.1016/j.zemedi.2022.11.008 |
0.675 |
|
| 2023 |
Delker A, Schleske M, Liubchenko G, Berg I, Zacherl MJ, Brendel M, Gildehaus FJ, Rumiantcev M, Resch S, Hürkamp K, Wenter V, Unterrainer LM, Bartenstein P, Ziegler SI, Beyer L, et al. Biodistribution and dosimetry for combined [Lu]Lu-PSMA-I&T/[Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36629878 DOI: 10.1007/s00259-022-06092-1 |
0.487 |
|
| 2022 |
Völter F, Beyer L, Eckenweber F, Scheifele M, Bui N, Patt M, Barthel H, Katzdobler S, Palleis C, Franzmeier N, Levin J, Perneczky R, Rauchmann BS, Sabri O, Hong J, ... ... Bartenstein P, et al. Assessment of perfusion deficit with early phases of [F]PI-2620 tau-PET versus [F]flutemetamol-amyloid-PET recordings. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36572740 DOI: 10.1007/s00259-022-06087-y |
0.676 |
|
| 2022 |
Wiltgen T, Fleischmann DF, Kaiser L, Holzgreve A, Corradini S, Landry G, Ingrisch M, Popp I, Grosu AL, Unterrainer M, Bartenstein P, Parodi K, Belka C, Albert N, Niyazi M, et al. F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy. Radiation Oncology (London, England). 17: 198. PMID 36461120 DOI: 10.1186/s13014-022-02164-6 |
0.633 |
|
| 2022 |
Quach S, Holzgreve A, Kaiser L, Unterrainer M, Dekorsy FJ, Nelwan DV, Bartos LM, Kirchleitner SV, Weller J, Weidner L, Niyazi M, Ruf VC, Herms J, Stöcklein S, Wetzel C, ... ... Bartenstein P, et al. TSPO PET signal using [F]GE180 is associated with survival in recurrent gliomas. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36329288 DOI: 10.1007/s00259-022-06006-1 |
0.783 |
|
| 2022 |
Bartos LM, Kirchleitner SV, Blobner J, Wind K, Kunze LH, Holzgreve A, Gold L, Zatcepin A, Kolabas ZI, Ulukaya S, Weidner L, Quach S, Messerer D, Bartenstein P, Tonn JC, et al. 18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model. Frontiers in Medicine. 9: 992993. PMID 36325388 DOI: 10.3389/fmed.2022.992993 |
0.718 |
|
| 2022 |
Fischer M, Zacherl MJ, Olivier J, Lindner S, Massberg S, Bartenstein P, Grawe F, Ziegler S, Brendel M, Lehner S, Boening G, Todica A. Detection of apoptosis by [F]ML-10 after cardiac ischemia-reperfusion injury in mice. Annals of Nuclear Medicine. PMID 36306025 DOI: 10.1007/s12149-022-01801-0 |
0.475 |
|
| 2022 |
Unterrainer LM, Todica A, Beyer L, Brendel M, Holzgreve A, Kauffmann-Guerrero D, Unterrainer M, Bartenstein P, Tufman A. Ga-EMP-100 PET/CT-a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36253641 DOI: 10.1007/s00259-022-05995-3 |
0.53 |
|
| 2022 |
von Rohr K, Unterrainer M, Holzgreve A, Kirchner MA, Li Z, Unterrainer LM, Suchorska B, Brendel M, Tonn JC, Bartenstein P, Ziegler S, Albert NL, Kaiser L. Can Radiomics Provide Additional Information in [F]FET-Negative Gliomas? Cancers. 14. PMID 36230783 DOI: 10.3390/cancers14194860 |
0.775 |
|
| 2022 |
Li Z, Holzgreve A, Unterrainer LM, Ruf VC, Quach S, Bartos LM, Suchorska B, Niyazi M, Wenter V, Herms J, Bartenstein P, Tonn JC, Unterrainer M, Albert NL, Kaiser L. Combination of pre-treatment dynamic [F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36227357 DOI: 10.1007/s00259-022-05988-2 |
0.725 |
|
| 2022 |
Katzdobler S, Nitschmann A, Barthel H, Bischof G, Beyer L, Marek K, Song M, Wagemann O, Palleis C, Weidinger E, Nack A, Fietzek U, Kurz C, Häckert J, Stapf T, ... ... Bartenstein P, et al. Additive value of [F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36102964 DOI: 10.1007/s00259-022-05964-w |
0.656 |
|
| 2022 |
Wängler C, Beyer L, Bartenstein P, Wängler B, Schirrmacher R, Lindner S. Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [F]SiTATE PET. Ejnmmi Radiopharmacy and Chemistry. 7: 22. PMID 36064987 DOI: 10.1186/s41181-022-00176-x |
0.391 |
|
| 2022 |
Rauchmann BS, Brendel M, Franzmeier N, Trappmann L, Zaganjori M, Ersoezlue E, Morenas-Rodriguez E, Guersel S, Burow L, Kurz C, Haeckert J, Tatò M, Utecht J, Papazov B, Pogarell O, ... ... Bartenstein P, et al. Microglial Activation and Connectivity in Alzheimer Disease and Aging. Annals of Neurology. PMID 36053756 DOI: 10.1002/ana.26465 |
0.487 |
|
| 2022 |
Becker-Bense S, Kaiser L, Becker R, Feil K, Muth C, Albert NL, Unterrainer M, Bartenstein P, Strupp M, Dieterich M. Acetyl-DL-leucine in cerebellar ataxia ([F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks? Journal of Neurology. PMID 35876876 DOI: 10.1007/s00415-022-11252-2 |
0.649 |
|
| 2022 |
Dekorsy FJ, Beyer L, Spitzweg C, Schmidmaier R, Todica A, Trupka A, Cyran CC, Berger F, Ladurner R, Zimmermann P, Knösel T, Bartenstein P, Lottspeich C, Wenter V. Preoperative Imaging with [F]-Fluorocholine PET/CT in Primary Hyperparathyroidism. Journal of Clinical Medicine. 11. PMID 35629070 DOI: 10.3390/jcm11102944 |
0.466 |
|
| 2022 |
Unterrainer LM, Beyer L, Zacherl MJ, Gildehaus FJ, Todica A, Kunte SC, Holzgreve A, Sheikh GT, Herlemann A, Casuscelli J, Brendel M, Albert NL, Wenter V, Schmidt-Hegemann NS, Kunz WG, ... ... Bartenstein P, et al. Total Tumor Volume on F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with Ac-PSMA-I&T. Biomedicines. 10. PMID 35625683 DOI: 10.3390/biomedicines10050946 |
0.686 |
|
| 2022 |
Quach S, Holzgreve A, von Baumgarten L, Niyazi M, Unterrainer M, Thon N, Stöcklein S, Bartenstein P, Tonn JC, Albert NL. Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma-indicator for treatment-induced immune activation? European Journal of Nuclear Medicine and Molecular Imaging. PMID 35610517 DOI: 10.1007/s00259-022-05844-3 |
0.562 |
|
| 2022 |
Bartos LM, Kunte ST, Beumers P, Xiang X, Wind K, Ziegler S, Bartenstein P, Choi H, Lee DS, Haass C, von Baumgarten L, Tahirovic S, Albert NL, Lindner S, Brendel M. Single cell radiotracer allocation via immunomagentic sorting (scRadiotracing) to disentangle PET signals at cellular resolution. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 35589403 DOI: 10.2967/jnumed.122.264171 |
0.752 |
|
| 2022 |
Holzgreve A, Pötter D, Brendel M, Orth M, Weidner L, Gold L, Kirchner MA, Bartos LM, Unterrainer LM, Unterrainer M, Steiger K, von Baumgarten L, Niyazi M, Belka C, Bartenstein P, et al. Longitudinal [F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model. Biomedicines. 10. PMID 35453488 DOI: 10.3390/biomedicines10040738 |
0.743 |
|
| 2022 |
Blume T, Deussing M, Biechele G, Peters F, Zott B, Schmidt C, Franzmeier N, Wind K, Eckenweber F, Sacher C, Shi Y, Ochs K, Kleinberger G, Xiang X, Focke C, ... ... Bartenstein P, et al. Chronic PPARγ Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves Cognition. Frontiers in Aging Neuroscience. 14: 854031. PMID 35431893 DOI: 10.3389/fnagi.2022.854031 |
0.587 |
|
| 2022 |
Messerschmidt K, Barthel H, Brendel M, Scherlach C, Hoffmann KT, Rauchmann BS, Rullmann M, Marek K, Villemagne VL, Rumpf JJ, Saur D, Schroeter ML, Schildan A, Patt M, Beyer L, ... ... Bartenstein P, et al. F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 35422444 DOI: 10.2967/jnumed.121.262854 |
0.674 |
|
| 2022 |
Antons M, Lindner M, Grosch M, Oos R, Palumbo G, Brendel M, Ziegler S, Bartenstein P, Dieterich M, Zwergal A. Longitudinal []UCB-H/[F]FDG imaging depicts complex patterns of structural and functional neuroplasticity following bilateral vestibular loss in the rat. Scientific Reports. 12: 6049. PMID 35411002 DOI: 10.1038/s41598-022-09936-w |
0.591 |
|
| 2022 |
Fischer M, Weinberger T, Messerer D, Zacherl MJ, Schulz C, Massberg S, Bartenstein P, Lehner S, Boening G, Todica A. Comparison of transient and permanent LAD ligation in mice using 18F-FDG PET imaging. Annals of Nuclear Medicine. PMID 35355159 DOI: 10.1007/s12149-022-01734-8 |
0.357 |
|
| 2022 |
Fischer M, Olivier J, Lindner S, Zacherl MJ, Massberg S, Bartenstein P, Ziegler S, Brendel M, Lehner S, Boening G, Todica A. Detection of cardiac apoptosis by [F]ML-10 in a mouse model of permanent LAD ligation. Molecular Imaging and Biology. PMID 35352214 DOI: 10.1007/s11307-022-01718-0 |
0.47 |
|
| 2022 |
Unterrainer LM, Lindner S, Eismann L, Casuscelli J, Gildehaus FJ, Bui VN, Albert NL, Holzgreve A, Beyer L, Todica A, Brendel M, Cyran CC, Karl A, Stief CG, Ledderose ST, ... ... Bartenstein P, et al. Feasibility of [Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. PMID 35325283 DOI: 10.1007/s00259-022-05761-5 |
0.698 |
|
| 2022 |
Franzmeier N, Brendel M, Beyer L, Slemann L, Kovacs GG, Arzberger T, Kurz C, Respondek G, Lukic MJ, Biel D, Rubinski A, Frontzkowski L, Hummel S, Müller A, Finze A, ... ... Bartenstein P, et al. Tau deposition patterns are associated with functional connectivity in primary tauopathies. Nature Communications. 13: 1362. PMID 35292638 DOI: 10.1038/s41467-022-28896-3 |
0.542 |
|
| 2022 |
Ilhan H, Kroenke M, Wurzer A, Unterrainer M, Heck M, Belka C, Knorr K, Langbein T, Rauscher I, Schmidt-Hegemann NS, Schiller K, Bartenstein P, Wester HJ, Eiber M. F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer after Curative-intent Radiation Therapy: A Bicentric Retrospective Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 35273094 DOI: 10.2967/jnumed.121.262861 |
0.323 |
|
| 2022 |
Zatcepin A, Heindl S, Schillinger U, Kaiser L, Lindner S, Bartenstein P, Kopczak A, Liesz A, Brendel M, Ziegler SI. Reduced Acquisition Time [F]GE-180 PET Scanning Protocol Replaces Gold-Standard Dynamic Acquisition in a Mouse Ischemic Stroke Model. Frontiers in Medicine. 9: 830020. PMID 35223925 DOI: 10.3389/fmed.2022.830020 |
0.542 |
|
| 2022 |
Holzgreve A, Völter F, Delker A, Kunz WG, Fabritius MP, Brendel M, Albert NL, Bartenstein P, Unterrainer M, Unterrainer LM. Detection of Splenic Tissue Using Tc-Labelled Denatured Red Blood Cells Scintigraphy-A Quantitative Single Center Analysis. Diagnostics (Basel, Switzerland). 12. PMID 35204576 DOI: 10.3390/diagnostics12020486 |
0.615 |
|
| 2022 |
Schuster S, Beyer L, Palleis C, Harris S, Schmitt J, Weidinger E, Prix C, Bötzel K, Danek A, Rauchmann BS, Stöcklein S, Lindner S, Unterrainer M, Albert NL, Mittlmeier LM, ... ... Bartenstein P, et al. Impact of Partial Volume Correction on [F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome. Brain Sciences. 12. PMID 35203967 DOI: 10.3390/brainsci12020204 |
0.728 |
|
| 2022 |
Unterrainer M, Mahler C, Schumacher AM, Ruf V, Blum B, Quach S, Brendel M, Rupprecht R, Bartenstein P, Kerschensteiner M, Kümpfel T, Albert NL. Amino Acid Uptake, Glucose Metabolism, and Neuroinflammation in John Cunningham Virus Associated Progressive Multifocal Leukoencephalopathy. Clinical Nuclear Medicine. PMID 35195584 DOI: 10.1097/RLU.0000000000004093 |
0.753 |
|
| 2022 |
Finze A, Wahl H, Janowitz D, Buerger K, Linn J, Rominger A, Stöcklein S, Bartenstein P, Wollenweber FA, Catak C, Brendel M. Regional Associations of Cortical Superficial Siderosis and β-Amyloid-Positron-Emission-Tomography Positivity in Patients With Cerebral Amyloid Angiopathy. Frontiers in Aging Neuroscience. 13: 786143. PMID 35185518 DOI: 10.3389/fnagi.2021.786143 |
0.537 |
|
| 2021 |
Kaiser L, Holzgreve A, Quach S, Ingrisch M, Unterrainer M, Dekorsy FJ, Lindner S, Ruf V, Brosch-Lenz J, Delker A, Böning G, Suchorska B, Niyazi M, Wetzel CH, Riemenschneider MJ, ... ... Bartenstein P, et al. Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in Gliomas. Cancers. 14. PMID 35008218 DOI: 10.3390/cancers14010053 |
0.76 |
|
| 2021 |
Vettermann FJ, Diekmann C, Weidner L, Unterrainer M, Suchorska B, Ruf V, Dorostkar M, Wenter V, Herms J, Tonn JC, Bartenstein P, Riemenschneider MJ, Albert NL. L-type amino acid transporter (LAT) 1 expression in F-FET-negative gliomas. Ejnmmi Research. 11: 124. PMID 34905134 DOI: 10.1186/s13550-021-00865-9 |
0.632 |
|
| 2021 |
Kirchner MA, Holzgreve A, Brendel M, Orth M, Ruf VC, Steiger K, Pötter D, Gold L, Unterrainer M, Mittlmeier LM, Barci E, Kälin RE, Glass R, Lindner S, Kaiser L, ... ... Bartenstein P, et al. PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook. Frontiers in Oncology. 11: 774017. PMID 34869017 DOI: 10.3389/fonc.2021.774017 |
0.725 |
|
| 2021 |
Mittlmeier LM, Todica A, Gildehaus FJ, Unterrainer M, Beyer L, Brendel M, Albert NL, Ledderose ST, Vettermann FJ, Schott M, Rodler S, Marcon J, Ilhan H, Cyran CC, Stief CG, ... ... Bartenstein P, et al. Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging results. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34708249 DOI: 10.1007/s00259-021-05596-6 |
0.678 |
|
| 2021 |
Hadi I, Biczok A, Terpolilli N, Thorsteinsdottir J, Forbrig R, Albert NL, Yanchovski P, Zollner B, Bodensohn R, Corradini S, Bartenstein P, Belka C, Tonn JC, Schichor C, Niyazi M. Multimodal therapy of cavernous sinus meningioma: Impact of surgery and Ga-DOTATATE PET-guided radiation therapy on tumor control and functional outcome. Neuro-Oncology Advances. 3: vdab114. PMID 34704034 DOI: 10.1093/noajnl/vdab114 |
0.501 |
|
| 2021 |
Xiang X, Wind K, Wiedemann T, Blume T, Shi Y, Briel N, Beyer L, Biechele G, Eckenweber F, Zatcepin A, Lammich S, Ribicic S, Tahirovic S, Willem M, Deussing M, ... ... Bartenstein P, et al. Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases. Science Translational Medicine. 13: eabe5640. PMID 34644146 DOI: 10.1126/scitranslmed.abe5640 |
0.594 |
|
| 2021 |
Rogowski P, Trapp C, von Bestenbostel R, Eze C, Ganswindt U, Li M, Unterrainer M, Zacherl MJ, Ilhan H, Beyer L, Kretschmer A, Bartenstein P, Stief C, Belka C, Schmidt-Hegemann NS. Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34628521 DOI: 10.1007/s00259-021-05557-z |
0.306 |
|
| 2021 |
Biechele G, Blume T, Deussing M, Zott B, Shi Y, Xiang X, Franzmeier N, Kleinberger G, Peters F, Ochs K, Focke C, Sacher C, Wind K, Schmidt C, Lindner S, ... ... Bartenstein P, et al. Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation. Theranostics. 11: 8964-8976. PMID 34522221 DOI: 10.7150/thno.64022 |
0.629 |
|
| 2021 |
Li Z, Kaiser L, Holzgreve A, Ruf VC, Suchorska B, Wenter V, Quach S, Herms J, Bartenstein P, Tonn JC, Unterrainer M, Albert NL. Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [F]FET PET radiomics. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34490493 DOI: 10.1007/s00259-021-05526-6 |
0.623 |
|
| 2021 |
Holzgreve A, Fabritius MP, Knösel T, Mittlmeier LM, Rübenthaler J, Tiling R, Auernhammer CJ, Bartenstein P, Unterrainer M. Molecular Imaging with F-FDG PET/CT and Tc-MIBI SPECT/CT in Osteitis Fibrosa Cystica Generalisata. Diagnostics (Basel, Switzerland). 11. PMID 34441290 DOI: 10.3390/diagnostics11081355 |
0.409 |
|
| 2021 |
Lehner S, Graner FP, Fischer M, Ilhan H, Bartenstein P, Todica A. The assessment of left ventricular mechanical dyssynchrony from gated Tc-tetrofosmin SPECT and gated F-FDG PET by QGS: a comparative study. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. PMID 34282536 DOI: 10.1007/s12350-021-02737-0 |
0.432 |
|
| 2021 |
Willroider M, Roeber S, Horn AKE, Arzberger T, Scheifele M, Respondek G, Sabri O, Barthel H, Patt M, Mishchenko O, Schildan A, Mueller A, Koglin N, Stephens A, Levin J, ... ... Bartenstein P, et al. Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for Assessment of Progressive Supranuclear Palsy Tau Pathology With [ F]PI-2620. Frontiers in Neurology. 12: 684523. PMID 34276540 DOI: 10.3389/fneur.2021.684523 |
0.568 |
|
| 2021 |
Mittlmeier LM, Suchorska B, Ruf V, Holzgreve A, Brendel M, Herms J, Bartenstein P, Tonn JC, Unterrainer M, Albert NL. F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors. Cancers. 13. PMID 34202726 DOI: 10.3390/cancers13133163 |
0.784 |
|
| 2021 |
Fabritius MP, Geyer T, Ahmaddy F, Albert NL, Bartenstein P, Tiling R, Rübenthaler J, Holzgreve A. Breast Cancer Metastasis Mimicking Meningioma in 68Ga-DOTATOC PET/CT. Clinical Nuclear Medicine. PMID 34132678 DOI: 10.1097/RLU.0000000000003770 |
0.567 |
|
| 2021 |
Fischer M, Zacherl MJ, Weckbach L, Paintmayer L, Weinberger T, Stark K, Massberg S, Bartenstein P, Lehner S, Schulz C, Todica A. Cardiac 18F-FDG Positron Emission Tomography: An Accurate Tool to Monitor Metabolic and Functional Alterations in Murine Myocardial Infarction. Frontiers in Cardiovascular Medicine. 8: 656742. PMID 34113662 DOI: 10.3389/fcvm.2021.656742 |
0.335 |
|
| 2021 |
Mittlmeier LM, Brendel M, Beyer L, Albert NL, Todica A, Zacherl MJ, Wenter V, Herlemann A, Kretschmer A, Ledderose ST, Schmidt-Hegemann NS, Kunz WG, Ricke J, Bartenstein P, Ilhan H, et al. Feasibility of Different Tumor Delineation Approaches for F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients. Frontiers in Oncology. 11: 663631. PMID 34094956 DOI: 10.3389/fonc.2021.663631 |
0.76 |
|
| 2021 |
Vettermann FJ, Harris S, Schmitt J, Unterrainer M, Lindner S, Rauchmann BS, Palleis C, Weidinger E, Beyer L, Eckenweber F, Schuster S, Biechele G, Ferschmann C, Milenkovic VM, Wetzel CH, ... ... Bartenstein P, et al. Impact of TSPO Receptor Polymorphism on [F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative Disorders. Life (Basel, Switzerland). 11. PMID 34073557 DOI: 10.3390/life11060484 |
0.763 |
|
| 2021 |
Schmitt J, Palleis C, Sauerbeck J, Unterrainer M, Harris S, Prix C, Weidinger E, Katzdobler S, Wagemann O, Danek A, Beyer L, Rauchmann BS, Rominger A, Simons M, Bartenstein P, et al. Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome. Frontiers in Aging Neuroscience. 13: 661284. PMID 34054506 DOI: 10.3389/fnagi.2021.661284 |
0.659 |
|
| 2021 |
Song M, Beyer L, Kaiser L, Barthel H, van Eimeren T, Marek K, Nitschmann A, Scheifele M, Palleis C, Respondek G, Kern M, Biechele G, Hammes J, Bischof G, Barbe M, ... ... Bartenstein P, et al. Binding characteristics of [F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211018904. PMID 34044665 DOI: 10.1177/0271678X211018904 |
0.516 |
|
| 2021 |
Song M, Scheifele M, Barthel H, van Eimeren T, Beyer L, Marek K, Eckenweber F, Palleis C, Kaiser L, Finze A, Kern M, Nitschmann A, Biechele G, Katzdobler S, Bischof G, ... ... Bartenstein P, et al. Feasibility of short imaging protocols for [F]PI-2620 tau-PET in progressive supranuclear palsy. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34021393 DOI: 10.1007/s00259-021-05391-3 |
0.679 |
|
| 2021 |
Biechele G, Sebastian Monasor L, Wind K, Blume T, Parhizkar S, Arzberger T, Sacher C, Beyer L, Eckenweber F, Gildehaus FJ, von Ungern-Sternberg B, Willem M, Bartenstein P, Cumming P, Rominger A, et al. Glitter in the Darkness? Non-fibrillar β-amyloid Plaque Components Significantly Impact the β-amyloid PET Signal in Mouse Models of Alzheimer's Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34016733 DOI: 10.2967/jnumed.120.261858 |
0.612 |
|
| 2021 |
Unterrainer M, Ruf V, von Rohr K, Suchorska B, Mittlmeier LM, Beyer L, Brendel M, Wenter V, Kunz WG, Bartenstein P, Herms J, Niyazi M, Tonn JC, Albert NL. TERT-Promoter Mutational Status in Glioblastoma - Is There an Association With Amino Acid Uptake on Dynamic F-FET PET? Frontiers in Oncology. 11: 645316. PMID 33996563 DOI: 10.3389/fonc.2021.645316 |
0.736 |
|
| 2021 |
Palleis C, Brendel M, Finze A, Weidinger E, Bötzel K, Danek A, Beyer L, Nitschmann A, Kern M, Biechele G, Rauchmann BS, Häckert J, Höllerhage M, Stephens AW, Drzezga A, ... ... Bartenstein P, et al. Cortical [ F]PI-2620 Binding Differentiates Corticobasal Syndrome Subtypes. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33951244 DOI: 10.1002/mds.28624 |
0.5 |
|
| 2021 |
Beyer L, Gosewisch A, Lindner S, Völter F, Mittlmeier LM, Tiling R, Brendel M, Cyran CC, Unterrainer M, Rübenthaler J, Auernhammer CJ, Spitzweg C, Böning G, Gildehaus FJ, Jurkschat K, ... ... Bartenstein P, et al. Dosimetry and optimal scan time of [F]SiTATE-PET/CT in patients with neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33928401 DOI: 10.1007/s00259-021-05351-x |
0.655 |
|
| 2021 |
Holzgreve A, Biczok A, Ruf VC, Liesche-Starnecker F, Steiger K, Kirchner MA, Unterrainer M, Mittlmeier L, Herms J, Schlegel J, Bartenstein P, Tonn JC, Albert NL, Suchorska B. PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging. Frontiers in Oncology. 11: 646387. PMID 33859946 DOI: 10.3389/fonc.2021.646387 |
0.547 |
|
| 2021 |
Grosch M, Beyer L, Lindner M, Kaiser L, Ahmadi SA, Stockbauer A, Bartenstein P, Dieterich M, Brendel M, Zwergal A, Ziegler S. Metabolic connectivity-based single subject classification by multi-regional linear approximation in the rat. Neuroimage. 235: 118007. PMID 33831550 DOI: 10.1016/j.neuroimage.2021.118007 |
0.57 |
|
| 2021 |
Mittlmeier LM, Ledderose ST, Schott M, Brendel M, Beyer L, Theurich S, Mayr D, Walz C, Kunz WG, Ricke J, Bartenstein P, Ilhan H, Staehler M, Unterrainer M. Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on F-PSMA-1007 PET/CT Due to Endothelial PSMA-Expression. Diagnostics (Basel, Switzerland). 11. PMID 33802288 DOI: 10.3390/diagnostics11030423 |
0.61 |
|
| 2021 |
Nuebling GS, Prix C, Brendel M, Beyer L, Wlasich E, Loosli SV, Barthel H, Sabri O, Bartenstein P, Vöglein J, Danek A, Rominger A, Edbauer D, Haass C, Levin J. Low-degree trisomy 21 mosaicism promotes early-onset Alzheimer disease. Neurobiology of Aging. PMID 33789815 DOI: 10.1016/j.neurobiolaging.2021.02.021 |
0.582 |
|
| 2021 |
Unterrainer M, Lindner S, Beyer L, Gildehaus FJ, Todica A, Mittlmeier LM, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Tonn JC, Albert NL, Bartenstein P, Ilhan H. PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATE. Clinical Nuclear Medicine. PMID 33782306 DOI: 10.1097/RLU.0000000000003607 |
0.65 |
|
| 2021 |
Mahler C, Schumacher AM, Unterrainer M, Kaiser L, Höllbacher T, Lindner S, Havla J, Ertl-Wagner B, Patzig M, Seelos K, Neitzel J, Mäurer M, Krumbholz M, Metz I, Brück W, ... ... Bartenstein P, et al. TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy. Brain : a Journal of Neurology. PMID 33757118 DOI: 10.1093/brain/awab127 |
0.579 |
|
| 2021 |
Kreuzer A, Sauerbeck J, Scheifele M, Stockbauer A, Schönecker S, Prix C, Wlasich E, Loosli SV, M Kazmierczak P, Unterrainer M, Catak C, Janowitz D, Pogarell O, Palleis C, Perneczky R, ... ... Bartenstein P, et al. Detection Gap of Right-Asymmetric Neuronal Degeneration by CERAD Test Battery in Alzheimer's Disease. Frontiers in Aging Neuroscience. 13: 611595. PMID 33603657 DOI: 10.3389/fnagi.2021.611595 |
0.701 |
|
| 2021 |
Wenter V, Albert NL, Ahmaddy F, Unterrainer M, Hornung J, Ilhan H, Bartenstein P, Spitzweg C, Kneidinger N, Todica A. The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective study. Bmc Cancer. 21: 139. PMID 33550991 DOI: 10.1186/s12885-020-07745-w |
0.463 |
|
| 2021 |
Schöberl F, Pradhan C, Grosch M, Brendel M, Jostes F, Obermaier K, Sowa C, Jahn K, Bartenstein P, Brandt T, Dieterich M, Zwergal A. Bilateral vestibulopathy causes selective deficits in recombining novel routes in real space. Scientific Reports. 11: 2695. PMID 33514827 DOI: 10.1038/s41598-021-82427-6 |
0.516 |
|
| 2021 |
Ahmaddy F, Burgard C, Beyer L, Koehler VF, Bartenstein P, Fabritius MP, Geyer T, Wenter V, Ilhan H, Spitzweg C, Todica A. F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib. Cancers. 13. PMID 33467085 DOI: 10.3390/cancers13020317 |
0.439 |
|
| 2021 |
Fischer M, Zacherl MJ, Weinberger T, Weckbach L, Huber B, Schulz C, Massberg S, Bartenstein P, Lehner S, Todica A. Comparison of metabolic and functional parameters using cardiac 18F-FDG-PET in early to mid-adulthood male and female mice. Ejnmmi Research. 11: 7. PMID 33464447 DOI: 10.1186/s13550-021-00748-z |
0.332 |
|
| 2021 |
Holzgreve A, Fabritius MP, Knösel T, Renz BW, Lindner LH, Di Gioia D, Bartenstein P, Rübenthaler J, Tiling R. 18F-FDG PET/CT for Monitoring of Disease Progression in Metastatic Perivascular Epithelioid Cell Tumor. Clinical Nuclear Medicine. 46: 156-158. PMID 33315683 DOI: 10.1097/RLU.0000000000003453 |
0.452 |
|
| 2021 |
Hadi I, Biczok A, Terpolilli N, Thorsteinsdottir J, Forbrig R, Albert N, Yanchovski P, Zollner B, Bodensohn R, Corradini S, Bartenstein P, Belka C, Tonn J, Schichor C, Niyazi M. OC-0078 Impact of surgery and PET-guided radiotherapy in therapy management of cavernous sinus meningioma Radiotherapy and Oncology. 161: S50-S51. DOI: 10.1016/s0167-8140(21)06772-4 |
0.544 |
|
| 2021 |
Fleischmann D, Buettner M, Unterrainer M, Corradini S, Zollner B, Hofmaier J, Bodensohn R, Thon N, Belka C, Bartenstein P, Albert N, Niyazi M. 18F-GE-180 TSPO PET in High-Grade Glioma RT Planning International Journal of Radiation Oncology*Biology*Physics. 111: e589. DOI: 10.1016/j.ijrobp.2021.07.1577 |
0.407 |
|
| 2021 |
Biechele G, Rauchmann B, Janowitz D, Buerger K, Franzmeier N, Weidinger E, Guersel S, Schuster S, Finze A, Harris S, Schmitt J, Beyer L, Lindner S, Unterrainer M, Eckenweber F, ... ... Bartenstein P, et al. Associations between sex, body mass index, and the individual microglial response in Alzheimer’s disease Alzheimer's & Dementia. 17. DOI: 10.1002/alz.052772 |
0.602 |
|
| 2021 |
Biechele G, Monasor LS, Wind K, Blume T, Parhizkar S, Arzberger T, Sacher C, Beyer L, Eckenweber F, Gildehaus FJ, von Ungern‐Sternberg B, Willem M, Bartenstein P, Cumming P, Rominger A, et al. Glitter in the darkness? Non‐fibrillar β‐amyloid plaque components significantly impact the β‐amyloid PET signal Alzheimer's & Dementia. 17. DOI: 10.1002/alz.051983 |
0.578 |
|
| 2020 |
Biechele G, Wind K, Blume T, Sacher C, Beyer L, Eckenweber F, Franzmeier N, Ewers M, Zott B, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Tahirovic S, Willem M, Bartenstein P, et al. Microglial Activation in the Right Amygdala-Entorhinal-Hippocampal Complex is Associated with Preserved Spatial Learning in App mice. Neuroimage. 117707. PMID 33385560 DOI: 10.1016/j.neuroimage.2020.117707 |
0.535 |
|
| 2020 |
Mittlmeier LM, Unterrainer M, Rodler S, Todica A, Albert NL, Burgard C, Cyran CC, Kunz WG, Ricke J, Bartenstein P, Stief CG, Ilhan H, Staehler M. F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33369689 DOI: 10.1007/s00259-020-05165-3 |
0.6 |
|
| 2020 |
Beyer L, Meyer-Wilmes J, Schönecker S, Schnabel J, Sauerbeck J, Scheifele M, Prix C, Unterrainer M, Catak C, Pogarell O, Palleis C, Perneczky R, Danek A, Buerger K, Bartenstein P, et al. Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study. Neuroimage. Clinical. 29: 102535. PMID 33369564 DOI: 10.1016/j.nicl.2020.102535 |
0.59 |
|
| 2020 |
Biechele G, Franzmeier N, Blume T, Ewers M, Luque JM, Eckenweber F, Sacher C, Beyer L, Ruch-Rubinstein F, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Cumming P, Bartenstein P, Rominger A, et al. Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases. Journal of Neuroinflammation. 17: 374. PMID 33317543 DOI: 10.1186/s12974-020-02046-2 |
0.587 |
|
| 2020 |
Palleis C, Sauerbeck J, Beyer L, Harris S, Schmitt J, Morenas-Rodriguez E, Finze A, Nitschmann A, Ruch-Rubinstein F, Eckenweber F, Biechele G, Blume T, Shi Y, Weidinger E, Prix C, ... ... Bartenstein P, et al. In Vivo Assessment of Neuroinflammation in 4-Repeat Tauopathies. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33245166 DOI: 10.1002/mds.28395 |
0.614 |
|
| 2020 |
Lindner S, Wängler C, Bailey JJ, Jurkschat K, Bartenstein P, Wängler B, Schirrmacher R. Radiosynthesis of [F]SiFAlin-TATE for clinical neuroendocrine tumor positron emission tomography. Nature Protocols. 15: 3827-3843. PMID 33230332 DOI: 10.1038/s41596-020-00407-y |
0.329 |
|
| 2020 |
Schmidt Hegemann NS, Rogowski P, Eze C, Schäfer C, Stief C, Lang S, Spohn S, Steffens R, Li M, Gratzke C, Schultze-Seemann W, Ilhan H, Fendler WP, Bartenstein P, Ganswindt U, et al. Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair Analysis. Cancers. 12. PMID 33207785 DOI: 10.3390/cancers12113395 |
0.415 |
|
| 2020 |
Holzgreve A, Pfluger T, Schmid I, Guntinas-Lichius O, Kunz WG, Ricke J, Bartenstein P, Albert NL, Unterrainer M. F-FDG PET/CT for Response Assessment in Pediatric Sebaceous Carcinoma of the Parotid Gland. Diagnostics (Basel, Switzerland). 10. PMID 33172066 DOI: 10.3390/diagnostics10110908 |
0.664 |
|
| 2020 |
Brendel M, Barthel H, van Eimeren T, Marek K, Beyer L, Song M, Palleis C, Gehmeyr M, Fietzek U, Respondek G, Sauerbeck J, Nitschmann A, Zach C, Hammes J, Barbe MT, ... ... Bartenstein P, et al. Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy. Jama Neurology. 77: 1408-1419. PMID 33165511 DOI: 10.1001/Jamaneurol.2020.2526 |
0.527 |
|
| 2020 |
Vettermann FJ, Unterrainer M, Ruf V, Fleischmann DF, Rupprecht R, Forbrig R, Herms J, Tonn JC, Belka C, Bartenstein P, Niyazi M, Albert NL. Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PET. Clinical Nuclear Medicine. PMID 33065624 DOI: 10.1097/RLU.0000000000003331 |
0.759 |
|
| 2020 |
Buchecker V, Waldron AM, van Dijk RM, Koska I, Brendel M, von Ungern-Sternberg B, Lindner S, Gildehaus FJ, Ziegler S, Bartenstein P, Potschka H. [F]MPPF and [F]FDG μPET imaging in rats: impact of transport and restraint stress. Ejnmmi Research. 10: 112. PMID 32990819 DOI: 10.1186/s13550-020-00693-3 |
0.545 |
|
| 2020 |
Lindner S, Simmet M, Gildehaus FJ, Jurkschat K, Wängler C, Wängler B, Bartenstein P, Schirrmacher R, Ilhan H. Automated production of [F]SiTATE on a Scintomics GRP™ platform for PET/CT imaging of neuroendocrine tumors. Nuclear Medicine and Biology. 88: 86-95. PMID 32828007 DOI: 10.1016/J.Nucmedbio.2020.07.008 |
0.431 |
|
| 2020 |
Ueberschaer M, Vettermann FJ, Forbrig R, Unterrainer M, Siller S, Biczok AM, Thorsteinsdottir J, Cyran CC, Bartenstein P, Tonn JC, Albert NL, Schichor C. Simpson Grade Revisited - Intraoperative Estimation of the Extent of Resection in Meningiomas Versus Postoperative Somatostatin Receptor Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging. Neurosurgery. 88: 140-146. PMID 32827256 DOI: 10.1093/neuros/nyaa333 |
0.571 |
|
| 2020 |
Völk S, Unterrainer M, Albert NL, Havla J, Gerdes LA, Schumacher M, Brendel M, Kaiser L, Adorjan K, Rupprecht R, Bartenstein P, Kümpfel T, Danek A. TSPO PET With 18F-GE-180 to Differentiate Variants of Multiple Sclerosis: Relapsing-Remitting Multiple Sclerosis, Tumefactive Demyelination, and Baló's Concentric Sclerosis. Clinical Nuclear Medicine. 45: e447-e448. PMID 32796248 DOI: 10.1097/RLU.0000000000003220 |
0.7 |
|
| 2020 |
Brendel M, Catak C, Beyer L, Linn J, Wahl H, Janowitz D, Rominger A, Patt M, Barthel H, Sabri O, Bartenstein P, Wollenweber FA. Colocalization of Tau but Not β-Amyloid with Cortical Superficial Siderosis in a Case with Probable CAA. Case Reports in Neurology. 12: 232-237. PMID 32774280 DOI: 10.1159/000506765 |
0.551 |
|
| 2020 |
Wenter V, Albert NL, Unterrainer M, Ahmaddy F, Ilhan H, Jellinek A, Knösel T, Bartenstein P, Spitzweg C, Lehner S, Todica A. Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32683470 DOI: 10.1007/s00259-020-04952-2 |
0.452 |
|
| 2020 |
Zacherl MJ, Todica A, Wängler C, Schirrmacher R, Hajebrahimi MA, Pircher J, Li X, Lindner S, Brendel M, Bartenstein P, Massberg S, Brunner S, Lehner S, Hacker M, Huber BC. Molecular imaging of cardiac CXCR4 expression in a mouse model of acute myocardial infarction using a novel Ga-mCXCL12 PET tracer. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. PMID 32676914 DOI: 10.1007/s12350-020-02262-6 |
0.531 |
|
| 2020 |
Eckenweber F, Medina-Luque J, Blume T, Sacher C, Biechele G, Wind K, Deussing M, Briel N, Lindner S, Boening G, von Ungern-Sternberg B, Unterrainer M, Albert NL, Zwergal A, Levin J, ... Bartenstein P, et al. Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning. Journal of Neuroinflammation. 17: 208. PMID 32660586 DOI: 10.1186/S12974-020-01883-5 |
0.66 |
|
| 2020 |
Albert NL, Unterrainer M, Kaiser L, Brendel M, Vettermann FJ, Holzgreve A, Bartenstein P. In response to: Anatomy of F-GE180, a failed radioligand for the TSPO protein. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32524162 DOI: 10.1007/s00259-020-04885-w |
0.689 |
|
| 2020 |
Sacher C, Blume T, Beyer L, Biechele G, Sauerbeck J, Eckenweber F, Deussing M, Focke C, Parhizkar S, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Baumann K, Tahirovic S, Kleinberger G, ... ... Bartenstein P, et al. Asymmetry of fibrillar plaque burden in amyloid mouse models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32414948 DOI: 10.2967/Jnumed.120.242750 |
0.606 |
|
| 2020 |
Becker-Bense S, Willoch F, Stephan T, Brendel M, Yakushev I, Habs M, Ziegler S, Herz M, Schwaiger M, Dieterich M, Bartenstein P. Direct comparison of activation maps during galvanic vestibular stimulation: A hybrid H2[15 O] PET-BOLD MRI activation study. Plos One. 15: e0233262. PMID 32413079 DOI: 10.1371/journal.pone.0233262 |
0.617 |
|
| 2020 |
Beyer L, Nitschmann A, Barthel H, van Eimeren T, Unterrainer M, Sauerbeck J, Marek K, Song M, Palleis C, Respondek G, Hammes J, Barbe MT, Onur Ö, Jessen F, Saur D, ... ... Bartenstein P, et al. Early-phase [F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32318783 DOI: 10.1007/S00259-020-04788-W |
0.66 |
|
| 2020 |
Unterrainer M, Eze C, Ilhan H, Marschner S, Roengvoraphoj O, Schmidt-Hegemann NS, Walter F, Kunz WG, Rosenschöld PMA, Jeraj R, Albert NL, Grosu AL, Niyazi M, Bartenstein P, Belka C. Recent advances of PET imaging in clinical radiation oncology. Radiation Oncology (London, England). 15: 88. PMID 32317029 DOI: 10.1186/s13014-020-01519-1 |
0.612 |
|
| 2020 |
Mittlmeier LM, Unterrainer M, Todica A, Clevert DA, Cyran CC, Schmoeckel E, Rodler S, Bartenstein P, Stief CG, Ilhan H, Staehler M. Advanced Molecular Imaging in Histologically Verified Metanephric Adenoma. Urology. 140: e10-e11. PMID 32171695 DOI: 10.1016/j.urology.2020.02.025 |
0.327 |
|
| 2020 |
Beyer L, Brendel M, Scheiwein F, Sauerbeck J, Hosakawa C, Alberts I, Shi K, Bartenstein P, Ishii K, Seibyl J, Cumming P, Rominger A. Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography. Journal of Alzheimer's Disease : Jad. PMID 31985461 DOI: 10.3233/Jad-190818 |
0.589 |
|
| 2020 |
Connolly D, Bailey JJ, Ilhan H, Bartenstein P, Wängler C, Wängler B, Wuest M, Wuest F, Schirrmacher R. 18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor (SiFA) for Positron Emission Tomography. Journal of Visualized Experiments : Jove. PMID 31984969 DOI: 10.3791/60623 |
0.333 |
|
| 2020 |
Fleischmann DF, Unterrainer M, Schön R, Corradini S, Maihöfer C, Bartenstein P, Belka C, Albert NL, Niyazi M. Margin reduction in radiotherapy for glioblastoma through F-fluoroethyltyrosine PET? - A recurrence pattern analysis. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 145: 49-55. PMID 31923709 DOI: 10.1016/j.radonc.2019.12.005 |
0.664 |
|
| 2020 |
Schöberl F, Pradhan C, Irving S, Buerger K, Xiong G, Kugler G, Kohlbecher S, Engmann J, Werner P, Brendel M, Schneider E, Perneczky R, Jahn K, la Fougère C, Bartenstein P, et al. Real-space navigation testing differentiates between amyloid-positive and -negative aMCI. Neurology. PMID 31896617 DOI: 10.1212/Wnl.0000000000008758 |
0.459 |
|
| 2020 |
Ilhan H, Lindner S, Todica A, Cyran CC, Tiling R, Auernhammer CJ, Spitzweg C, Boeck S, Unterrainer M, Gildehaus FJ, Böning G, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, ... Bartenstein P, et al. Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors. European Journal of Nuclear Medicine and Molecular Imaging. 47: 870-880. PMID 31492994 DOI: 10.1007/S00259-019-04501-6 |
0.392 |
|
| 2020 |
Brendel M, Barthel H, Eimeren Tv, Marek K, Beyer L, Song M, Palleis C, Hammes J, Saur D, Schroeter ML, Rumpf J, Rullmann M, Schildan A, Patt M, Madonia J, ... ... Bartenstein P, et al. 18F-PI2620 Tau-PET in progressive supranuclear palsy: A multi-center evaluation The Journal of Nuclear Medicine. 60: 54-54. DOI: 10.1055/S-0040-1708120 |
0.436 |
|
| 2020 |
Brendel M, Palleis C, Prix C, Finze A, Boetzel K, Danek A, Höllerhage M, Beyer L, Sauerbeck J, Rauchmann B, Stephens AW, Drzezga A, van Eimeren T, Barthel H, Patt M, ... ... Bartenstein P, et al. 18
F‐PI‐2620 tau‐PET in corticobasal syndrome (ActiGliA cohort) Alzheimer's & Dementia. 16. DOI: 10.1002/ALZ.041469 |
0.414 |
|
| 2020 |
Biechele G, Franzmeier N, Ewers M, Blume T, Eckenweber F, Sacher C, Luque JM, Beyer L, Ruch‐Rubinstein F, Lindner S, Gildehaus FJ, von Ungern‐Sternberg B, Bartenstein P, Rominger A, Höglinger G, et al. Microglial activation in vivo is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of Alzheimer’s disease Alzheimer's & Dementia. 16. DOI: 10.1002/alz.039574 |
0.472 |
|
| 2020 |
Biechele G, Sacher C, Blume T, Beyer L, Sauerbeck J, Eckenweber F, Deussing M, Focke C, Parhizkar S, Lindner S, Gildehaus FJ, von Ungern‐Sternberg B, Baumann K, Tahirovic S, Kleinberger G, ... ... Bartenstein P, et al. Asymmetry of plaque burden in amyloid mouse models Alzheimer's & Dementia. 16. DOI: 10.1002/alz.039153 |
0.455 |
|
| 2019 |
Blautzik J, Grelich L, Schramm N, Henkel R, Bartenstein P, Pfluger T. What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours. Ejnmmi Research. 9: 115. PMID 31872312 DOI: 10.1186/s13550-019-0577-7 |
0.425 |
|
| 2019 |
Huber M, Beyer L, Prix C, Schönecker S, Palleis C, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Van Laere K, Kramberger MG, Trost M, Grmek M, Garibotto V, ... ... Bartenstein P, et al. Metabolic correlates of dopaminergic loss in dementia with lewy bodies. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31840326 DOI: 10.1002/Mds.27945 |
0.574 |
|
| 2019 |
Unterrainer M, Ruf V, Cyran CC, Brendel M, Thon N, Herms J, Schüller U, Tonn JC, Bartenstein P, Albert NL. Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT. Clinical Nuclear Medicine. 44: 923-924. PMID 31584491 DOI: 10.1097/Rlu.0000000000002790 |
0.803 |
|
| 2019 |
Schönecker S, Brendel M, Palleis C, Beyer L, Höglinger GU, Schuh E, Rauchmann BS, Sauerbeck J, Rohrer G, Sonnenfeld S, Furukawa K, Ishiki A, Okamura N, Bartenstein P, Dieterich M, et al. PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes. Frontiers in Aging Neuroscience. 11: 249. PMID 31572166 DOI: 10.3389/fnagi.2019.00249 |
0.613 |
|
| 2019 |
Unterrainer M, Fleischmann DF, Vettermann F, Ruf V, Kaiser L, Nelwan D, Lindner S, Brendel M, Wenter V, Stöcklein S, Herms J, Milenkovic VM, Rupprecht R, Tonn JC, Belka C, ... Bartenstein P, et al. TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative F-GE-180 PET study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31486876 DOI: 10.1007/S00259-019-04491-5 |
0.754 |
|
| 2019 |
Wenter V, Jellinek A, Unterrainer M, Ahmaddy F, Lehner S, Albert NL, Bartenstein P, Knösel T, Spitzweg C, Ilhan H, Todica A. Long-term outcome of rare oncocytic papillary (Hürthle cell) thyroid carcinoma following (adjuvant) initial radioiodine therapy. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31410542 DOI: 10.1007/s00259-019-04456-8 |
0.441 |
|
| 2019 |
Vettermann F, Suchorska B, Unterrainer M, Nelwan D, Forbrig R, Ruf V, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL. Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic F-FET PET. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31410540 DOI: 10.1007/S00259-019-04477-3 |
0.635 |
|
| 2019 |
Beyer L, Schnabel J, Kazmierczak P, Ewers M, Schönecker S, Prix C, Meyer-Wilmes J, Unterrainer M, Catak C, Pogarell O, Perneczky R, Albert NL, Bartenstein P, Danek A, Buerger K, et al. Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease. Neuroimage. Clinical. 24: 101949. PMID 31398553 DOI: 10.1016/j.nicl.2019.101949 |
0.679 |
|
| 2019 |
Brendel M, Deussing M, Blume T, Kaiser L, Probst F, Overhoff F, Peters F, von Ungern-Sternberg B, Ryazanov S, Leonov A, Griesinger C, Zwergal A, Levin J, Bartenstein P, Yakushev I, et al. Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tau. Alzheimer's Research & Therapy. 11: 67. PMID 31370885 DOI: 10.1186/S13195-019-0522-Z |
0.598 |
|
| 2019 |
Ilhan H, Todica A, Lindner S, Boening G, Gosewisch A, Wängler C, Wängler B, Schirrmacher R, Bartenstein P. First-in-human F-SiFAlin-TATE PET/CT for NET imaging and theranostics. European Journal of Nuclear Medicine and Molecular Imaging. 46: 2400-2401. PMID 31352578 DOI: 10.1007/s00259-019-04448-8 |
0.434 |
|
| 2019 |
Fleischmann DF, Unterrainer M, Corradini S, Rottler M, Förster S, la Fougère C, Siepmann T, Schwaiger M, Bartenstein P, Belka C, Albert NL, Niyazi M. Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation. Plos One. 14: e0216111. PMID 31339892 DOI: 10.1371/journal.pone.0216111 |
0.637 |
|
| 2019 |
Sacher C, Blume T, Beyer L, Peters F, Eckenweber F, Sgobio C, Deussing M, Albert NL, Unterrainer M, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Brzak I, Neumann U, Saito T, ... ... Bartenstein P, et al. Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second Generation Amyloid-beta Mouse Model. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31302633 DOI: 10.2967/Jnumed.119.227322 |
0.709 |
|
| 2019 |
Götzl JK, Brendel M, Werner G, Parhizkar S, Sebastian Monasor L, Kleinberger G, Colombo AV, Deussing M, Wagner M, Winkelmann J, Diehl-Schmid J, Levin J, Fellerer K, Reifschneider A, Bultmann S, ... Bartenstein P, et al. Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism. Embo Molecular Medicine. PMID 31122931 DOI: 10.15252/Emmm.201809711 |
0.498 |
|
| 2019 |
Unterrainer M, Ruf V, Ilhan H, Vettermann F, Holzgreve A, Cyran CC, Tonn JC, Bartenstein P, Albert NL. Teaching NeuroImages: Advanced imaging of neurosarcoidosis with Ga-DOTATATE PET/CT. Neurology. 92: e2512-e2513. PMID 31110154 DOI: 10.1212/WNL.0000000000007544 |
0.705 |
|
| 2019 |
Galldiks N, Unterrainer M, Judov N, Stoffels G, Rapp M, Lohmann P, Vettermann F, Dunkl V, Suchorska B, Tonn JC, Kreth FW, Fink GR, Bartenstein P, Langen KJ, Albert NL. Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET - Clinical relevance in glioma patients. Neuro-Oncology. PMID 31077276 DOI: 10.1093/neuonc/noz083 |
0.621 |
|
| 2019 |
Bailey JJ, Kaiser L, Lindner SK, Wuest M, Thiel A, Soucy JP, Rosa-Neto P, Scott PJH, Unterrainer M, Kaplan DR, Wängler C, Wängler B, Bartenstein P, Bernard-Gauthier V, Schirrmacher R. First-in-Human Brain Imaging of [18F]TRACK, a PET tracer for Tropomyosin Receptor Kinases. Acs Chemical Neuroscience. PMID 31017386 DOI: 10.1021/Acschemneuro.9B00144 |
0.331 |
|
| 2019 |
Unterrainer M, Ruf V, Ilhan H, Vettermann FJ, Cyran CC, Niyazi M, Bartenstein P, Tonn JC, Albert NL. 68Ga-DOTATOC PET/CT Differentiates Meningioma From Dural Metastases. Clinical Nuclear Medicine. 44: 412-413. PMID 30829858 DOI: 10.1097/RLU.0000000000002513 |
0.668 |
|
| 2019 |
Albert NL, Unterrainer M, Brendel M, Kaiser L, Zweckstetter M, Cumming P, Bartenstein P. In response to: The validity of F-GE180 as a TSPO imaging agent. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30826897 DOI: 10.1007/S00259-019-04294-8 |
0.689 |
|
| 2019 |
Nack A, Brendel M, Nedelcu J, Daerr M, Nyamoya S, Beyer C, Focke C, Deussing M, Hoornaert C, Ponsaerts P, Schmitz C, Bartenstein P, Rominger A, Kipp M. Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models. Cells. 8. PMID 30696113 DOI: 10.3390/cells8020094 |
0.588 |
|
| 2019 |
Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, Xiong M, Ghasemigharagoz A, Katzmarski N, Krasemann S, Lichtenthaler SF, Müller SA, Colombo A, Monasor LS, ... ... Bartenstein P, et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nature Neuroscience. PMID 30617257 DOI: 10.1038/S41593-018-0296-9 |
0.495 |
|
| 2019 |
Unterrainer M, Ilhan H, Vettermann F, Cyran CC, Tonn JC, Niyazi M, Bartenstein P, Albert NL. Whole-Body Staging of Metastatic Atypical Meningioma Using 68Ga-DOTATATE PET/CT. Clinical Nuclear Medicine. 44: 227-228. PMID 30589668 DOI: 10.1097/RLU.0000000000002422 |
0.652 |
|
| 2019 |
Schramm N, Ingenhoff J, Dechant C, Treitl KM, Treitl M, Proft F, Schulze-Koops H, Hoffmann U, Bartenstein P, Rominger A, Czihal M. Diagnostic accuracy of positron emission tomography for assessment of disease activity in large vessel vasculitis. International Journal of Rheumatic Diseases. 22: 1371-1377. PMID 30565885 DOI: 10.1111/1756-185X.13440 |
0.382 |
|
| 2019 |
Schmidt-Hegemann NS, Eze C, Li M, Rogowski P, Schaefer C, Stief C, Buchner A, Zamboglou C, Fendler WP, Ganswindt U, Cyran C, Bartenstein P, Belka C, Ilhan H. Impact of Ga-PSMA PET/CT on the Radiotherapeutic Approach to Prostate Cancer in Comparison to CT: A Retrospective Analysis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 60: 963-970. PMID 30552203 DOI: 10.2967/jnumed.118.220855 |
0.343 |
|
| 2019 |
Kurch L, Hasenclever D, Kluge R, Georgi T, Tchavdarova L, Golombeck M, Sabri O, Eggert A, Brenner W, Sykora KW, Bengel FM, Rossig C, Körholz D, Schäfers M, Feuchtinger T, ... Bartenstein P, et al. Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial. Pediatric Blood & Cancer. 66: e27539. PMID 30426671 DOI: 10.1002/pbc.27539 |
0.409 |
|
| 2019 |
Brendel M, Barthel H, van Eimeren T, Marek K, Beyer L, Song M, Palleis C, Respondek G, Sauerbeck J, Hammes J, Barbe M, Onur OA, Jessen F, Saur D, Schroeter ML, ... ... Bartenstein P, et al. IC-P-161: 18F-PI2620 TAU-PET IN PROGRESSIVE SUPRANUCLEAR PALSY: A MULTI-CENTER EVALUATION Alzheimer's & Dementia. 15: P128-P129. DOI: 10.1016/j.jalz.2019.06.4276 |
0.611 |
|
| 2019 |
Brendel M, Barthel H, Eimeren Tv, Marek K, Beyer L, Song M, Palleis C, Respondek G, Sauerbeck J, Hammes J, Barbe M, Onur OA, Jessen F, Saur D, Schroeter ML, ... ... Bartenstein P, et al. Ic-P-161: 18F-Pi2620 Tau-Pet In Progressive Supranuclear Palsy: A Multi-Center Evaluation Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2783 |
0.611 |
|
| 2019 |
Ilhan H, Kroenke M, Wurzer A, Ulbrich L, Jooß L, Unterrainer M, Bartenstein P, Kropf S, Wester H, Weber W, Eiber M. 18f-Rhpsma-7 Positron Emission Tomography (PET) for the Detection of Biochemical Recurrence after Primary Radiation Therapy of Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 105: E280. DOI: 10.1016/j.ijrobp.2019.06.1911 |
0.345 |
|
| 2019 |
Unterrainer M, Niyazi M, Tonn JC, Ilhan H, Bartenstein P, Albert NL. A look ahead: future directions of SSR-directed imaging and therapy in meningioma Clinical and Translational Imaging. 7: 357-362. DOI: 10.1007/s40336-019-00333-4 |
0.466 |
|
| 2019 |
Unterrainer M, Niyazi M, Tonn JC, Ilhan H, Bartenstein P, Albert NL. Current status of SSR-directed imaging and therapy in meningioma Clinical and Translational Imaging. 7: 171-180. DOI: 10.1007/s40336-019-00331-6 |
0.469 |
|
| 2018 |
Feil K, Brendel M, Hensler M, Bartenstein P, Seelos K, Dieterich M, Rominger A, Danek A. FDG-PET in a Case of Very Late-onset Huntington's Disease. Movement Disorders Clinical Practice. 5: 227-228. PMID 30746408 DOI: 10.1002/mdc3.12601 |
0.616 |
|
| 2018 |
Brendel M, Jaworska A, Overhoff F, Blume T, Probst F, Gildehaus FJ, Bartenstein P, Haass C, Bohrmann B, Herms J, Willem M, Rominger A. Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation. Theranostics. 8: 4957-4968. PMID 30429879 DOI: 10.7150/Thno.27868 |
0.587 |
|
| 2018 |
Mahler C, Unterrainer M, Muth C, Egensperger R, Vomacka L, Lindner S, Ertl-Wagner B, Patzig M, Bartenstein P, Albert N, Kerschensteiner M, Kümpfel T. Imaging microglial activation in tacrolimus-associated CNS vasculitis with translocator protein PET. Neurology. 91: 936-937. PMID 30420457 DOI: 10.1212/Wnl.0000000000006516 |
0.614 |
|
| 2018 |
Blume T, Focke C, Peters F, Deussing M, Albert NL, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Ozmen L, Baumann K, Bartenstein P, Rominger A, Herms J, Brendel M. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study. Journal of Neuroinflammation. 15: 307. PMID 30400912 DOI: 10.1186/S12974-018-1347-6 |
0.669 |
|
| 2018 |
van Dijk RM, Di Liberto V, Brendel M, Waldron AM, Möller C, Gildehaus FJ, von Ungern-Sternberg B, Lindner M, Ziegler S, Hellweg R, Gass P, Bartenstein P, Potschka H. Imaging biomarkers of behavioral impairments: A pilot micro-positron emission tomographic study in a rat electrical post-status epilepticus model. Epilepsia. PMID 30370531 DOI: 10.1111/epi.14586 |
0.558 |
|
| 2018 |
Focke C, Blume T, Zott B, Yuan Shi Y, Deussing M, Peters F, Schmidt C, Kleinberger G, Lindner S, Gildehaus FJ, Beyer L, von Ungern-Sternberg B, Bartenstein P, Ozmen L, Baumann K, et al. Early and longitudinal microglial activation but not amyloid accumulation predict cognitive outcome in PS2APP mice. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30262517 DOI: 10.2967/Jnumed.118.217703 |
0.547 |
|
| 2018 |
Unterrainer M, Fleischmann DF, Diekmann C, Vomacka L, Lindner S, Vettermann F, Brendel M, Wenter V, Ertl-Wagner B, Herms J, Wetzel C, Rupprecht R, Tonn JC, Belka C, Bartenstein P, et al. Comparison of F-GE-180 and dynamic F-FET PET in high grade glioma: a double-tracer pilot study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30244386 DOI: 10.1007/S00259-018-4166-1 |
0.766 |
|
| 2018 |
Vomacka L, Unterrainer M, Holzgreve A, Mille E, Gosewisch A, Brosch J, Ziegler S, Suchorska B, Kreth FW, Tonn JC, Bartenstein P, Albert NL, Böning G. Voxel-wise analysis of dynamic F-FET PET: a novel approach for non-invasive glioma characterisation. Ejnmmi Research. 8: 91. PMID 30203138 DOI: 10.1186/s13550-018-0444-y |
0.65 |
|
| 2018 |
Unterrainer M, Diekmann C, Dorostkar M, Vettermann FJ, Kümpfel T, Tonn JC, Bartenstein P, Albert NL. Neurosarcoidosis Mimics High-Grade Glioma in Dynamic 18F-FET PET Due to LAT Expression. Clinical Nuclear Medicine. 43: 840-841. PMID 30179915 DOI: 10.1097/RLU.0000000000002266 |
0.655 |
|
| 2018 |
Irving S, Schöberl F, Pradhan C, Brendel M, Bartenstein P, Dieterich M, Brandt T, Zwergal A. A novel real-space navigation paradigm reveals age- and gender-dependent changes of navigational strategies and hippocampal activation. Journal of Neurology. PMID 30073501 DOI: 10.1007/s00415-018-8987-4 |
0.427 |
|
| 2018 |
Brendel M, Sauerbeck J, Greven S, Kotz S, Scheiwein F, Blautzik J, Delker A, Pogarell O, Ishii K, Bartenstein P, Rominger A. Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms. Journal of Alzheimer's Disease : Jad. 65: 793-806. PMID 30010116 DOI: 10.3233/JAD-170387 |
0.5 |
|
| 2018 |
Schmidt-Hegemann NS, Stief C, Kim TH, Eze C, Kirste S, Strouthos I, Li M, Schultze-Seemann W, Ilhan H, Fendler WP, Bartenstein P, Grosu AL, Ganswindt U, Belka C, Meyer PT, et al. Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30002108 DOI: 10.2967/jnumed.118.212563 |
0.365 |
|
| 2018 |
Beyer L, Meyer-Wilmes J, Schönecker S, Schnabel J, Brendel E, Prix C, Nübling G, Unterrainer M, Albert NL, Pogarell O, Perneczky R, Catak C, Bürger K, Bartenstein P, Bötzel K, et al. Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging? Frontiers in Neurology. 9: 483. PMID 29973914 DOI: 10.3389/fneur.2018.00483 |
0.76 |
|
| 2018 |
Suchorska B, Unterrainer M, Biczok A, Sosnova M, Forbrig R, Bartenstein P, Tonn JC, Albert NL, Kreth FW. F-FET-PET as a biomarker for therapy response in non-contrast enhancing glioma following chemotherapy. Journal of Neuro-Oncology. 139: 721-730. PMID 29948765 DOI: 10.1007/s11060-018-2919-0 |
0.638 |
|
| 2018 |
Di Liberto V, Maarten van Dijk R, Brendel M, Waldron AM, Möller C, Koska I, Seiffert I, Gualtieri F, Gildehaus FJ, von Ungern-Sternberg B, Lindner M, Ziegler S, Palme R, Hellweg R, Gass P, ... Bartenstein P, et al. Imaging correlates of behavioral impairments: An experimental PET study in the rat pilocarpine epilepsy model. Neurobiology of Disease. PMID 29933054 DOI: 10.1016/J.Nbd.2018.06.010 |
0.63 |
|
| 2018 |
Brendel M, Yousefi BH, Blume T, Herz M, Focke C, Deussing M, Peters F, Lindner S, von Ungern-Sternberg B, Drzezga A, Bartenstein P, Haass C, Okamura N, Herms J, Yakushev I, et al. Comparison of F-T807 and F-THK5117 PET in a Mouse Model of Tau Pathology. Frontiers in Aging Neuroscience. 10: 174. PMID 29930508 DOI: 10.3389/Fnagi.2018.00174 |
0.663 |
|
| 2018 |
Deussing M, Blume T, Vomacka L, Mahler C, Focke C, Todica A, Unterrainer M, Albert NL, Lindner S, von Ungern-Sternberg B, Baumann K, Zwergal A, Bartenstein P, Herms J, Rominger A, et al. Data on specificity of [F]GE180 uptake for TSPO expression in rodent brain and myocardium. Data in Brief. 19: 331-336. PMID 29892655 DOI: 10.1016/J.Dib.2018.04.133 |
0.712 |
|
| 2018 |
Roengvoraphoj O, Eze C, Wijaya C, Dantes M, Taugner J, Tufman A, Huber RM, Bartenstein P, Belka C, Manapov F. How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29876620 DOI: 10.1007/s00259-018-4063-7 |
0.327 |
|
| 2018 |
Unterrainer M, Fleischmann DF, Lindner S, Brendel M, Rupprecht R, Tonn JC, Belka C, Bartenstein P, Niyazi M, Albert NL. Detection of Cerebrospinal Fluid Dissemination of Recurrent Glioblastoma Using TSPO-PET With 18F-GE-180. Clinical Nuclear Medicine. 43: 518-519. PMID 29742608 DOI: 10.1097/RLU.0000000000002113 |
0.802 |
|
| 2018 |
Sauerbeck J, Ishii K, Hosokawa C, Kaida H, Scheiwein FT, Hanaoka K, Rominger A, Brendel M, Bartenstein P, Murakami T. The correlation between striatal and cortical binding ratio of C-PiB-PET in amyloid-uptake-positive patients. Annals of Nuclear Medicine. 32: 398-403. PMID 29730823 DOI: 10.1007/s12149-018-1258-8 |
0.581 |
|
| 2018 |
Hartenbach M, Weber S, Pilz M, Hartenbach S, Zacherl MJ, Paprottka PM, Tiling R, Bartenstein P, Hacker M, Haug AR, Albert NL. Combined [18F]-Fluoroethylcholine PET/CT and 99mTc-Macroaggregated Albumin SPECT/CT Predict Survival in Patients With Intermediate-Stage Hepatocellular Carcinoma. Clinical Nuclear Medicine. 43: 477-481. PMID 29659390 DOI: 10.1097/RLU.0000000000002092 |
0.626 |
|
| 2018 |
Fiedler L, Kellner M, Gosewisch A, Oos R, Böning G, Lindner S, Albert N, Bartenstein P, Reulen HJ, Zeidler R, Gildehaus FJ. Evaluation of Lu[Lu]-CHX-A″-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII. Nuclear Medicine and Biology. 60: 55-62. PMID 29571067 DOI: 10.1016/j.nucmedbio.2018.02.004 |
0.465 |
|
| 2018 |
Unterrainer M, Winkelmann I, Suchorska B, Giese A, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL. Correction to: Biological tumour volumes of gliomas in early and standard 20-40 minF-FET PET images differ according to IDH mutation status. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29541813 DOI: 10.1007/s00259-018-3991-6 |
0.544 |
|
| 2018 |
Unterrainer M, Mahler C, Vomacka L, Lindner S, Havla J, Brendel M, Böning G, Ertl-Wagner B, Kümpfel T, Milenkovic VM, Rupprecht R, Kerschensteiner M, Bartenstein P, Albert NL. TSPO PET with [F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis. European Journal of Nuclear Medicine and Molecular Imaging. 45: 1423-1431. PMID 29523925 DOI: 10.1007/S00259-018-3974-7 |
0.736 |
|
| 2018 |
Schmidt-Hegemann NS, Fendler WP, Ilhan H, Herlemann A, Buchner A, Stief C, Eze C, Rogowski P, Li M, Bartenstein P, Ganswindt U, Belka C. Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy. Radiation Oncology (London, England). 13: 37. PMID 29499730 DOI: 10.1186/s13014-018-0983-4 |
0.32 |
|
| 2018 |
Unterrrainer M, Winkelmann I, Suchorska B, Giese A, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL. Biological tumour volumes of gliomas in early and standard 20-40 minF-FET PET images differ according to IDH mutation status. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29487977 DOI: 10.1007/S00259-018-3969-4 |
0.639 |
|
| 2018 |
Unterrainer M, Maihoefer C, Cyran CC, Bartenstein P, Niyazi M, Albert NL. 68Ga-DOTATATE PET/CT Reveals Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma in a Case of Suspected Sphenoid Wing Meningioma. Clinical Nuclear Medicine. PMID 29401153 DOI: 10.1097/RLU.0000000000001985 |
0.613 |
|
| 2018 |
Eschbach RS, Kazmierczak PM, Heimer MM, Todica A, Hirner-Eppeneder H, Schneider MJ, Keinrath G, Solyanik O, Olivier J, Kunz WG, Reiser MF, Bartenstein P, Ricke J, Cyran CC. 18F-FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanoma. Cancer Imaging : the Official Publication of the International Cancer Imaging Society. 18: 2. PMID 29347968 DOI: 10.1186/s40644-018-0135-y |
0.389 |
|
| 2018 |
Suchorska B, Vettermann F, Unterrainer M, Nelwan D, Forbrig R, Dorostkar M, Kreth F, Bartenstein P, Tonn J, Lisa Albert N. NIMG-41. NON-INVASIVE DETECTION OF IDH-WILDTYPE GENOTYPE IN GLIOMAS USING DYNAMIC 18F-FET-PET Neuro-Oncology. 20: vi185-vi185. DOI: 10.1093/neuonc/noy148.767 |
0.382 |
|
| 2018 |
Ueberschaer M, Vettermann F, Forbrig R, Bartenstein P, Albert NL, Tonn J, Schichor C. MNGI-35. SIMPSON GRADING REVISITED: SURGEONS ESTIMATION OF MENINGIOMA REMOVAL VS. POSTOPERATIVE 68GA-DOTATATE PET/CT Neuro-Oncology. 20: vi156-vi156. DOI: 10.1093/NEUONC/NOY148.651 |
0.577 |
|
| 2018 |
Niyazi M, Fleischmann D, Unterrainer M, Bartenstein P, Albert N, Belka C. PO-0723: TSPO-PET for RT treatment planning using [18F]GE-180 – first in human results in GBM p atients Radiotherapy and Oncology. 127: S369-S370. DOI: 10.1016/s0167-8140(18)31033-8 |
0.627 |
|
| 2017 |
Brendel M, Wagner L, Levin J, Zach C, Lindner S, Bartenstein P, Okamura N, Rominger A. Perfusion-Phase [F]THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration. Journal of Alzheimer's Disease Reports. 1: 109-113. PMID 30480233 DOI: 10.3233/ADR-170023 |
0.676 |
|
| 2017 |
Brendel M, Schönecker S, Höglinger G, Lindner S, Havla J, Blautzik J, Sauerbeck J, Rohrer G, Zach C, Vettermann F, Lang AE, Golbe L, Nübling G, Bartenstein P, Furukawa K, et al. [18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy. Frontiers in Aging Neuroscience. 9: 440. PMID 29387005 DOI: 10.3389/fnagi.2017.00440 |
0.643 |
|
| 2017 |
Zwergal A, Günther L, Brendel M, Beck R, Lindner S, Xiong G, Eilles E, Unterrainer M, Albert NL, Becker-Bense S, Brandt T, Ziegler S, la Fougère C, Dieterich M, Bartenstein P. In Vivo Imaging of Glial Activation after Unilateral Labyrinthectomy in the Rat: A [18F]GE180-PET Study. Frontiers in Neurology. 8: 665. PMID 29312111 DOI: 10.3389/fneur.2017.00665 |
0.721 |
|
| 2017 |
Vomacka L, Albert NL, Lindner S, Unterrainer M, Mahler C, Brendel M, Ermoschkin L, Gosewisch A, Brunegraf A, Buckley C, Kümpfel T, Rupprecht R, Ziegler S, Kerschensteiner M, Bartenstein P, et al. TSPO imaging using the novel PET ligand [(18)F]GE-180: quantification approaches in patients with multiple sclerosis. Ejnmmi Research. 7: 89. PMID 29150726 DOI: 10.1186/S13550-017-0340-X |
0.756 |
|
| 2017 |
Herlemann A, Kretschmer A, Buchner A, Karl A, Tritschler S, El-Malazi L, Fendler WP, Wenter V, Ilhan H, Bartenstein P, Stief CG, Gratzke C. Salvage lymph node dissection after (68)Ga-PSMA or (18)F-FEC PET/CT for nodal recurrence in prostate cancer patients. Oncotarget. 8: 84180-84192. PMID 29137414 DOI: 10.18632/oncotarget.21118 |
0.343 |
|
| 2017 |
Schmidt-Hegemann NS, Fendler WP, Buchner A, Stief C, Rogowski P, Niyazi M, Eze C, Li M, Bartenstein P, Belka C, Ganswindt U. Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy. Radiation Oncology (London, England). 12: 176. PMID 29126446 DOI: 10.1186/s13014-017-0902-0 |
0.315 |
|
| 2017 |
Unterrainer M, Niyazi M, Ruf V, Bartenstein P, Albert NL. The endothelial prostate-specific membrane antigen is highly expressed in gliosarcoma and visualized by [68Ga]-PSMA-11 PET: a theranostic outlook for brain tumor patients? Neuro-Oncology. 19: 1698-1699. PMID 29045711 DOI: 10.1093/neuonc/nox172 |
0.537 |
|
| 2017 |
Suchorska B, Giese A, Biczok A, Unterrainer M, Weller M, Drexler M, Bartenstein P, Schüller U, Tonn JC, Albert NL. Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma. Neuro-Oncology. PMID 29016996 DOI: 10.1093/neuonc/nox153 |
0.623 |
|
| 2017 |
Deussing M, Blume T, Vomacka L, Mahler C, Focke C, Todica A, Unterrainer M, Albert NL, Lindner S, von Ungern-Sternberg B, Baumann K, Zwergal A, Bartenstein P, Herms J, Rominger A, et al. Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [(18)F]GE180 PET quantification. Neuroimage. PMID 28988133 DOI: 10.1016/J.Neuroimage.2017.10.006 |
0.717 |
|
| 2017 |
Brendel M, Schnabel J, Schönecker S, Wagner L, Brendel E, Meyer-Wilmes J, Unterrainer M, Schildan A, Patt M, Prix C, Ackl N, Catak C, Pogarell O, Levin J, Danek A, ... ... Bartenstein P, et al. Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET. European Journal of Nuclear Medicine and Molecular Imaging. PMID 28932894 DOI: 10.1007/s00259-017-3832-z |
0.677 |
|
| 2017 |
Todica A, Beetz NL, Günther L, Zacherl MJ, Grabmaier U, Huber B, Bartenstein P, Brunner S, Lehner S. Monitoring of Cardiac Remodeling in a Mouse Model of Pressure-Overload Left Ventricular Hypertrophy with [(18)F]FDG MicroPET. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 28852941 DOI: 10.1007/s11307-017-1114-6 |
0.328 |
|
| 2017 |
Albert NL, Unterrainer M, Fleischmann DF, Lindner S, Vettermann F, Brunegraf A, Vomacka L, Brendel M, Wenter V, Wetzel C, Rupprecht R, Tonn JC, Belka C, Bartenstein P, Niyazi M. TSPO PET for glioma imaging using the novel ligand (18)F-GE-180: first results in patients with glioblastoma. European Journal of Nuclear Medicine and Molecular Imaging. PMID 28821920 DOI: 10.1007/s00259-017-3799-9 |
0.752 |
|
| 2017 |
Filss CP, Albert NL, Böning G, Kops ER, Suchorska B, Stoffels G, Galldiks N, Shah NJ, Mottaghy FM, Bartenstein P, Tonn JC, Langen KJ. O-(2-[(18)F]fluoroethyl)-L-tyrosine PET in gliomas: influence of data processing in different centres. Ejnmmi Research. 7: 64. PMID 28815478 DOI: 10.1186/s13550-017-0316-x |
0.664 |
|
| 2017 |
Unterrainer M, Ilhan H, Todica A, Bartenstein P, Albert NL. Epidural Metastases From Follicular Thyroid Cancer Mimicking Meningiomas in 68Ga-DOTATATE PET. Clinical Nuclear Medicine. 42: 805-806. PMID 28806249 DOI: 10.1097/RLU.0000000000001793 |
0.563 |
|
| 2017 |
Brendel M, Focke C, Blume T, Peters F, Deussing M, Probst F, Jaworska A, Overhoff F, Albert N, Lindner S, von Ungern-Sternberg B, Bartenstein P, Haass C, Kleinberger G, Herms J, et al. Time Courses of Cortical Glucose Metabolism and Microglial Activity Across the Life-Span of Wild-Type Mice: A PET Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28705919 DOI: 10.2967/Jnumed.117.195107 |
0.71 |
|
| 2017 |
Blautzik J, Kotz S, Brendel M, Sauerbeck J, Vettermann F, Winter Y, Bartenstein P, Ishii K, Rominger A. Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 28697560 DOI: 10.3233/JAD-170064 |
0.568 |
|
| 2017 |
Unterrainer M, Vettermann F, Brendel M, Holzgreve A, Lifschitz M, Zähringer M, Suchorska B, Wenter V, Illigens BM, Bartenstein P, Albert NL. Towards standardization of (18)F-FET PET imaging: do we need a consistent method of background activity assessment? Ejnmmi Research. 7: 48. PMID 28560582 DOI: 10.1186/s13550-017-0295-y |
0.754 |
|
| 2017 |
Kleinberger G, Brendel M, Mracsko E, Wefers B, Groeneweg L, Xiang X, Focke C, Deußing M, Suárez-Calvet M, Mazaheri F, Parhizkar S, Pettkus N, Wurst W, Feederle R, Bartenstein P, et al. The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism. The Embo Journal. PMID 28559417 DOI: 10.15252/Embj.201796516 |
0.52 |
|
| 2017 |
Wenter V, Herlemann A, Fendler WP, Ilhan H, Tirichter N, Bartenstein P, Stief CG, la Fougère C, Albert NL, Rominger A, Gratzke C. Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy. Oncotarget. 8: 44131-44140. PMID 28484088 DOI: 10.18632/oncotarget.17311 |
0.471 |
|
| 2017 |
Russmann V, Brendel M, Mille E, Helm-Vicidomini A, Beck R, Günther L, Lindner S, Rominger A, Keck M, Salvamoser JD, Albert NL, Bartenstein P, Potschka H. Identification of brain regions predicting epileptogenesis by serial [(18)F]GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy. Neuroimage. Clinical. 15: 35-44. PMID 28462087 DOI: 10.1016/j.nicl.2017.04.003 |
0.72 |
|
| 2017 |
Kunz WG, Jungblut LM, Kazmierczak PM, Vettermann FJ, Bollenbacher A, Tonn JC, Schichor C, Rominger A, Albert NL, Bartenstein P, Reiser MF, Cyran CC. Improved Detection of Transosseous Meningiomas Using Ga-DOTATATE PET/CT Compared with Contrast-Enhanced MRI. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 58: 1580-1587. PMID 28450556 DOI: 10.2967/jnumed.117.191932 |
0.628 |
|
| 2017 |
Blautzik J, Brendel M, Sauerbeck J, Kotz S, Scheiwein F, Bartenstein P, Seibyl J, Rominger A. Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden. European Journal of Nuclear Medicine and Molecular Imaging. 44: 1364-1374. PMID 28326436 DOI: 10.1007/s00259-017-3666-8 |
0.595 |
|
| 2017 |
Brendel M, Kleinberger G, Probst F, Jaworska A, Overhoff F, Blume T, Albert NL, Carlsen J, Lindner S, Gildehaus FJ, Ozmen L, Suárez-Calvet M, Bartenstein P, Baumann K, Ewers M, et al. Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis. Frontiers in Aging Neuroscience. 9: 8. PMID 28197095 DOI: 10.3389/Fnagi.2017.00008 |
0.685 |
|
| 2017 |
Daerr S, Brendel M, Zach C, Mille E, Schilling D, Zacherl MJ, Bürger K, Danek A, Pogarell O, Schildan A, Patt M, Barthel H, Sabri O, Bartenstein P, Rominger A. Evaluation of early-phase [(18)F]-florbetaben PET acquisition in clinical routine cases. Neuroimage. Clinical. 14: 77-86. PMID 28138429 DOI: 10.1016/j.nicl.2016.10.005 |
0.67 |
|
| 2017 |
Fleischmann DF, Unterrainer M, Bartenstein P, Belka C, Albert NL, Niyazi M. F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images? Journal of Neuro-Oncology. 132: 277-286. PMID 28102485 DOI: 10.1007/s11060-016-2366-8 |
0.678 |
|
| 2017 |
Vettermann FJ, Neumann JE, Suchorska B, Bartenstein P, Giese A, Dorostkar MM, Albert NL, Schüller U. K27M midline gliomas display malignant progression by imaging and histology. Neuropathology and Applied Neurobiology. 43: 458-462. PMID 27997032 DOI: 10.1111/nan.12371 |
0.505 |
|
| 2017 |
Unterrainer M, Galldiks N, Suchorska B, Kowalew LC, Wenter V, Schmid-Tannwald C, Niyazi M, Bartenstein P, Langen KJ, Albert NL. F-FET PET Uptake Characteristics in Patients with Newly Diagnosed and Untreated Brain Metastasis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 58: 584-589. PMID 27754904 DOI: 10.2967/jnumed.116.180075 |
0.66 |
|
| 2017 |
Wenter V, Albert NL, Brendel M, Fendler WP, Cyran CC, Bartenstein P, Friederichs J, Müller JP, Militz M, Hacker M, Hungerer S. [(18)F]FDG PET accurately differentiates infected and non-infected non-unions after fracture fixation. European Journal of Nuclear Medicine and Molecular Imaging. 44: 432-440. PMID 27704194 DOI: 10.1007/s00259-016-3528-9 |
0.666 |
|
| 2017 |
Scheiwein FT, Ishii K, Hosokawa C, Kaida H, Hyodo T, Hanaoka K, Brendel M, Bartenstein P, Rominger A, Murakami T. Regional Differences in Amyloid Deposition between 11C-Pib PET Positive Patients with and without Elevated Striatal Amyloid Uptake Journal of Alzheimer’S Disease & Parkinsonism. 7. DOI: 10.4172/2161-0460.1000317 |
0.57 |
|
| 2017 |
Suchorska B, Sosnova M, Unterrainer M, Biczok A, Bartenstein P, Albert N, Tonn J. NIMG-39. PATTERNS OF INTERSECTIONAL TUMOUR VOLUME IN T2-WEIGHTED MRI AND 18F-FET PET CORRELATE WITH OUTCOME IN GLIOBLASTOMA Neuro-Oncology. 19: vi150-vi150. DOI: 10.1093/NEUONC/NOX168.614 |
0.715 |
|
| 2017 |
Fleischmann D, Unterrainer M, Corradini S, Rottler M, Bartenstein P, Belka C, Albert N, Niyazi M. EP-1124: PET-MRI prior to re-irradiation of high-grade glioma patients - a planning study Radiotherapy and Oncology. 123: S613-S614. DOI: 10.1016/S0167-8140(17)31560-8 |
0.597 |
|
| 2017 |
Fleischmann D, Albert N, Unterrainer M, Bartenstein P, Belka C, Niyazi M. EP-1122: TSPO PET imaging RT treatment planning in malignant glioma Radiotherapy and Oncology. 123: S613. DOI: 10.1016/S0167-8140(17)31558-X |
0.597 |
|
| 2017 |
Fleischmann D, Unterrainer M, Schön R, Corradini S, Maihöfer C, Bartenstein P, Belka C, Albert N, Niyazi M. PO-0638: FET PET prior to primary RT of glioblastoma patients - a recurrence pattern analysis Radiotherapy and Oncology. 123: S334. DOI: 10.1016/S0167-8140(17)31075-7 |
0.598 |
|
| 2017 |
Zwergal A, Günther L, Brendel M, Beck R, Lindner S, Xiong G, Eilles E, Unterrainer M, Albert N, Becker-Bense S, Ziegler S, la Fougere C, Bartenstein P, Brandt T, Dieterich M. P 61 Glial activation accelerates behavioural compensation of acute unilateral vestibulopathy Clinical Neurophysiology. 128: e358. DOI: 10.1016/j.clinph.2017.06.137 |
0.6 |
|
| 2016 |
Schönecker S, Prix C, Raiser T, Ackl N, Wlasich E, Stenglein-Krapf G, Mille E, Brendel M, Sabri O, Patt M, Barthel H, Bartenstein P, Levin J, Rominger A, Danek A. [Amyloid positron-emission-tomography with [(18) F]-florbetaben in the diagnostic workup of dementia patients]. Der Nervenarzt. PMID 27913818 DOI: 10.1007/s00115-016-0249-z |
0.637 |
|
| 2016 |
Romagna A, Unterrainer M, Schmid-Tannwald C, Brendel M, Tonn JC, Nachbichler SB, Muacevic A, Bartenstein P, Kreth FW, Albert NL. Suspected recurrence of brain metastases after focused high dose radiotherapy: can [(18)F]FET- PET overcome diagnostic uncertainties? Radiation Oncology (London, England). 11: 139. PMID 27769279 DOI: 10.1186/s13014-016-0713-8 |
0.733 |
|
| 2016 |
Werner RA, Lapa C, Ilhan H, Higuchi T, Buck AK, Lehner S, Bartenstein P, Bengel F, Schatka I, Muegge DO, Papp L, Zsótér N, Große-Ophoff T, Essler M, Bundschuh RA. Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity. Oncotarget. PMID 27705948 DOI: 10.18632/oncotarget.12402 |
0.319 |
|
| 2016 |
Mille E, Levin J, Brendel M, Zach C, Barthel H, Sabri O, Bötzel K, Bartenstein P, Danek A, Rominger A. Cerebral Glucose Metabolism and Dopaminergic Function in Patients with Corticobasal Syndrome. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 27572945 DOI: 10.1111/jon.12391 |
0.484 |
|
| 2016 |
Wollenweber FA, Därr S, Müller C, Duering M, Buerger K, Zietemann V, Malik R, Brendel M, Ertl-Wagner B, Bartenstein P, Rominger A, Dichgans M. Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment. Stroke; a Journal of Cerebral Circulation. PMID 27539301 DOI: 10.1161/STROKEAHA.116.013778 |
0.533 |
|
| 2016 |
Deutschländer A, la Fougère C, Boetzel K, Albert NL, Gildehaus FJ, Bartenstein P, Xiong G, Cumming P. Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients. Neuroimage. Clinical. 12: 41-6. PMID 27408789 DOI: 10.1016/J.Nicl.2016.06.007 |
0.537 |
|
| 2016 |
Holzgreve A, Brendel M, Gu S, Carlsen J, Mille E, Böning G, Mastrella G, Unterrainer M, Gildehaus FJ, Rominger A, Bartenstein P, Kälin RE, Glass R, Albert NL. Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches. Frontiers in Neuroscience. 10: 260. PMID 27378835 DOI: 10.3389/fnins.2016.00260 |
0.753 |
|
| 2016 |
Barthel H, Meyer PT, Drzezga A, Bartenstein P, Boecker H, Brust P, Buchert R, Coenen HH, la Fougère C, Gründer G, Grünwald F, Krause BJ, Kuwert T, Schreckenberger M, Tatsch K, et al. [German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging]. Nuklearmedizin. Nuclear Medicine. 55. PMID 27080914 DOI: 10.3413/Nukmed-0816-16-04 |
0.333 |
|
| 2016 |
Unterrainer M, Schweisthal F, Suchorska B, Wenter V, Schmid-Tannwald C, Fendler WP, Schüller U, Bartenstein P, Tonn JC, Albert NL. Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense? Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 57: 1177-82. PMID 27033893 DOI: 10.2967/jnumed.115.171033 |
0.654 |
|
| 2016 |
Högenauer M, Brendel M, Delker A, Därr S, Weiss M, Bartenstein P, Rominger A, Alzheimer's Disease Neuroimaging Initiative. Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation. Current Alzheimer Research. 13: 597-607. PMID 27025775 DOI: 10.2174/156720501304160325175855 |
0.657 |
|
| 2016 |
Overhoff F, Brendel M, Jaworska A, Korzhova V, Delker A, Probst F, Focke C, Gildehaus FJ, Carlsen J, Baumann K, Haass C, Bartenstein P, Herms J, Rominger A. Automated Spatial Brain Normalization and Hindbrain White Matter Reference Tissue Give Improved [(18)F]-Florbetaben PET Quantitation in Alzheimer's Model Mice. Frontiers in Neuroscience. 10: 45. PMID 26973442 DOI: 10.3389/Fnins.2016.00045 |
0.606 |
|
| 2016 |
Brendel M, Reinisch V, Kalinowski E, Levin J, Delker A, Därr S, Pogarell O, Förster S, Bartenstein P, Rominger A, Alzheimer's Disease Neuroimaging Initiative. Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects. Current Alzheimer Research. 13: 475-86. PMID 26971944 DOI: 10.2174/1567205013666160314143922 |
0.611 |
|
| 2016 |
Brendel M, Jaworska A, Probst F, Overhoff F, Korzhova V, Lindner S, Carlsen J, Bartenstein P, Harada R, Kudo Y, Haass C, van Leuven F, Okamura N, Herms J, Rominger A. microPET Imaging of Tau Pathology with [18F]-THK5117 in two Transgenic Mouse Models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26912432 DOI: 10.2967/Jnumed.115.163493 |
0.567 |
|
| 2016 |
Brendel M, Probst F, Jaworska A, Overhoff F, Korzhova V, Albert N, Beck R, Lindner S, Gildehaus FJ, Baumann K, Bartenstein P, Kleinberger G, Haass C, Herms J, Rominger A. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple Tracer PET Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26912428 DOI: 10.2967/Jnumed.115.167858 |
0.704 |
|
| 2016 |
Herlemann A, Wenter V, Kretschmer A, Thierfelder KM, Bartenstein P, Faber C, Gildehaus FJ, Stief CG, Gratzke C, Fendler WP. (68)Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer. European Urology. PMID 26810345 DOI: 10.1016/j.eururo.2015.12.051 |
0.301 |
|
| 2016 |
Albert NL, Unterrainer M, Diemling M, Xiong G, Bartenstein P, Koch W, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu LÖ, Kluge A, Ziebell M, et al. Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26780619 DOI: 10.1007/S00259-015-3304-2 |
0.492 |
|
| 2016 |
Lindner S, Rensch C, Neubaur S, Neumeier M, Salvamoser R, Samper V, Bartenstein P. Azeotropic drying free [(18)F]FDG synthesis and its application to a lab-on-chip platform. Chemical Communications (Cambridge, England). 52: 729-32. PMID 26561572 DOI: 10.1039/c5cc07106b |
0.309 |
|
| 2016 |
Zwergal A, Schlichtiger J, Xiong G, Beck R, Günther L, Schniepp R, Schöberl F, Jahn K, Brandt T, Strupp M, Bartenstein P, Dieterich M, Dutia MB, Fougère CL. Sequential [F-18]FDG A mu PET whole-brain imaging of central vestibular compensation: a model of deafferentation-induced brain plasticity Brain Structure & Function. 221. DOI: 10.15496/Publikation-18367 |
0.355 |
|
| 2016 |
Suchorska B, Kraus T, Biczok A, Weller M, Unterrainer M, Schueller U, Schmid-Tannwald C, Bartenstein P, Giese A, Tonn J, Albert NL. Correlation of IDH mutation, 1p/19q co-deletion and 18FET-PET derived time-to-peak analysis as prognostic markers in glioma Journal of Clinical Oncology. 34: 2058-2058. DOI: 10.1200/JCO.2016.34.15_SUPPL.2058 |
0.66 |
|
| 2016 |
Suchorska B, Kraus T, Biczok A, Weller M, Unterrainer M, Schüller U, Schmid-Tannwald C, Bartenstein P, Giese A, Albert N, Tonn J. NIMG-34. 18FET-PET UPTAKE DYNAMICS SERVES AS AN ADDITIONAL IMAGING BIOMARKER IN ASTROCYTOMAS WITH IDH1/2 MUTATION AND NO LOH1p/19q Neuro-Oncology. 18: vi131-vi132. DOI: 10.1093/neuonc/now212.546 |
0.692 |
|
| 2016 |
Fleischmann D, Unterrainer M, Bartenstein P, Belka C, Albert N, Niyazi M. PO-0650: Prognostic value of minimal time to peak in dynamic 18F-FET-PET for high-grade glioma re-irradiation Radiotherapy and Oncology. 119: S304. DOI: 10.1016/S0167-8140(16)31900-4 |
0.636 |
|
| 2016 |
Becker-Bense S, Stephan T, Albert N, Brendel M, Unterrainer M, Xiong G, Mille E, Habs M, Herz M, Schwaiger M, Dieterich M, Bartenstein P. EP 30. Hybrid-H215O-PET-fMRI measures during galvanic vestibular stimulation Clinical Neurophysiology. 127: e247-e248. DOI: 10.1016/j.clinph.2016.05.085 |
0.689 |
|
| 2015 |
Albert NL, Winkelmann I, Suchorska B, Wenter V, Schmid-Tannwald C, Mille E, Todica A, Brendel M, Tonn JC, Bartenstein P, la Fougère C. Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26666239 DOI: 10.1007/s00259-015-3276-2 |
0.765 |
|
| 2015 |
Michl M, Lehner S, Paprottka PM, Ilhan H, Bartenstein P, Heinemann V, Boeck S, Albert NL, Fendler WP. PET response criteria (PERCIST) predict progression-free survival and overall survival after radioembolization for liver metastases from pancreatic cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26609176 DOI: 10.2967/jnumed.115.165613 |
0.546 |
|
| 2015 |
Wenter V, Müller JP, Albert NL, Lehner S, Fendler WP, Bartenstein P, Cyran CC, Friederichs J, Militz M, Hacker M, Hungerer S. The diagnostic value of [(18)F]FDG PET for the detection of chronic osteomyelitis and implant-associated infection. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26547722 DOI: 10.1007/s00259-015-3221-4 |
0.643 |
|
| 2015 |
Araque Caballero MÁ, Brendel M, Delker A, Ren J, Rominger A, Bartenstein P, Dichgans M, Weiner MW, Ewers M. Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects. Neurobiology of Aging. 36: 2913-24. PMID 26476234 DOI: 10.1016/J.Neurobiolaging.2015.08.007 |
0.589 |
|
| 2015 |
Gross L, Paintmayer L, Lehner S, Brandl L, Brenner C, Grabmaier U, Huber B, Bartenstein P, Theiss HD, Franz WM, Massberg S, Todica A, Brunner S. FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarction. European Heart Journal Cardiovascular Imaging. PMID 26420287 DOI: 10.1093/ehjci/jev237 |
0.303 |
|
| 2015 |
Hartenbach M, Weber S, Albert NL, Hartenbach S, Hirtl A, Zacherl MJ, Paprottka PM, Tiling R, Bartenstein P, Hacker M, Haug AR. Evaluating Treatment Response of Radioembolization in Intermediate-Stage Hepatocellular Carcinoma Patients Using 18F-Fluoroethylcholine PET/CT. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1661-6. PMID 26405170 DOI: 10.2967/jnumed.115.158758 |
0.629 |
|
| 2015 |
Brendel M, Jaworska A, Herms J, Trambauer J, Rötzer C, Gildehaus FJ, Carlsen J, Cumming P, Bylund J, Luebbers T, Bartenstein P, Steiner H, Haass C, Baumann K, Rominger A. Monitoring of chronic γ-secretase modulator treatment by serial amyloid-PET. Molecular Psychiatry. 20: 1141. PMID 26401838 DOI: 10.1038/mp.2015.146 |
0.575 |
|
| 2015 |
Hetterich H, Rominger A, Walter L, Habs M, Volpers S, Hacker M, Reiser MF, Bartenstein P, Saam T. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT. The International Journal of Cardiovascular Imaging. PMID 25898891 DOI: 10.1007/s10554-015-0660-8 |
0.446 |
|
| 2015 |
Rominger A, Cumming P, Brendel M, Xiong G, Zach C, Karch S, Tatsch K, Bartenstein P, la Fougère C, Koch W, Pogarell O. Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 873-81. PMID 25819144 DOI: 10.1016/J.Euroneuro.2014.12.010 |
0.462 |
|
| 2015 |
Brendel M, Jaworska A, Grießinger E, Rötzer C, Burgold S, Gildehaus FJ, Carlsen J, Cumming P, Baumann K, Haass C, Steiner H, Bartenstein P, Herms J, Rominger A. Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models. Plos One. 10: e0116678. PMID 25706990 DOI: 10.1371/Journal.Pone.0116678 |
0.588 |
|
| 2015 |
Fendler WP, Chalkidis RP, Ilhan H, Knösel T, Herrmann K, Issels RD, Bartenstein P, Cyran CC, Lindner LH, Hacker M. Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence. European Radiology. 25: 2214-21. PMID 25693667 DOI: 10.1007/s00330-015-3654-y |
0.385 |
|
| 2015 |
Bailey DL, Antoch G, Bartenstein P, Barthel H, Beer AJ, Bisdas S, Bluemke DA, Boellaard R, Claussen CD, Franzius C, Hacker M, Hricak H, la Fougère C, Gückel B, Nekolla SG, et al. Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tübingen, Germany. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 297-312. PMID 25672749 DOI: 10.1007/s11307-014-0818-0 |
0.359 |
|
| 2015 |
Brendel M, Pogarell O, Xiong G, Delker A, Bartenstein P, Rominger A. Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients. European Journal of Nuclear Medicine and Molecular Imaging. 42: 716-24. PMID 25631614 DOI: 10.1007/s00259-014-2975-4 |
0.502 |
|
| 2015 |
Jansen NL, Suchorska B, Wenter V, Schmid-Tannwald C, Todica A, Eigenbrod S, Niyazi M, Tonn JC, Bartenstein P, Kreth FW, la Fougère C. Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 9-15. PMID 25537990 DOI: 10.2967/jnumed.114.144675 |
0.391 |
|
| 2015 |
Brendel M, Högenauer M, Delker A, Sauerbeck J, Bartenstein P, Seibyl J, Rominger A. Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction. Neuroimage. 108: 450-9. PMID 25482269 DOI: 10.1016/j.neuroimage.2014.11.055 |
0.625 |
|
| 2015 |
Suchorska B, Jansen NL, Kraus T, Giese A, Bartenstein P, Tonn J. Correlation of dynamic 18FET-PET with IDH 1 mutation for prediction of outcome in anaplastic astrocytoma WHO° III independently from tumor vascularisation. Journal of Clinical Oncology. 33: 2037-2037. DOI: 10.1200/JCO.2015.33.15_SUPPL.2037 |
0.522 |
|
| 2015 |
Brendel M, Jaworska A, Herms J, Trambauer J, Rötzer C, Gildehaus FJ, Carlsen J, Cumming P, Bylund J, Luebbers T, Bartenstein P, Steiner H, Haass C, Baumann K, Rominger A. Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment Molecular Psychiatry. DOI: 10.1038/mp.2015.74 |
0.549 |
|
| 2015 |
Simon-Vermot L, Zhang Y, Caballero MÁA, Gesierich B, Kambeitz-Ilankovic L, Brendel M, Rominger A, Bartenstein P, Duering M, Ewers M. Temporo-parietal hypometabolism is associated with reduced functional connectivity of the default mode network in prodromal Alzheimer's disease Alzheimers & Dementia. 11: 542. DOI: 10.1016/J.Jalz.2015.06.684 |
0.444 |
|
| 2015 |
Becker-Bense S, Feuerecker R, Xiong G, Feil K, Bartenstein P, Strupp M, Dieterich M. P37. Effects of acetyl-dl-leucine on the cerebral activation pattern in cerebellar ataxia (FDG-PET study) Clinical Neurophysiology. 126: e115. DOI: 10.1016/j.clinph.2015.04.175 |
0.36 |
|
| 2015 |
Schöberl F, Xiong G, Feil K, Bartenstein P, Fougere Cl, Brandt T, Jahn K, Strupp M, Dieterich M, Zwergal A. V12. [18F]-FDG-PET imaging of the cerebral orthostatic tremor network during stance Clinical Neurophysiology. 126: e71. DOI: 10.1016/j.clinph.2015.04.090 |
0.42 |
|
| 2014 |
Lehner S, Todica A, Vanchev Y, Uebleis C, Wang H, Herrler T, Wängler C, Cumming P, Böning G, Franz WM, Bartenstein P, Hacker M, Brunner S. In vivo monitoring of parathyroid hormone treatment after myocardial infarction in mice with [68Ga]annexin A5 and [18F]fluorodeoxyglucose positron emission tomography. Molecular Imaging. 13. PMID 25249170 DOI: 10.2310/7290.2014.00035 |
0.314 |
|
| 2014 |
Todica A, Zacherl MJ, Wang H, Böning G, Jansen NL, Wängler C, Bartenstein P, Kreissl MC, Hacker M, Brunner S, Lehner S. In-vivo monitoring of erythropoietin treatment after myocardial infarction in mice with [⁶⁸Ga]Annexin A5 and [¹⁸F]FDG PET. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 21: 1191-9. PMID 25189144 DOI: 10.1007/s12350-014-9987-0 |
0.314 |
|
| 2014 |
Hartenbach M, Delker A, Hartenbach S, Schlichtiger J, Niedermoser S, Wängler C, Wängler B, Böning G, Gildehaus FJ, Neumaier K, Lauber K, Kraft K, Belka C, Hacker M, Meineke V, ... Bartenstein P, et al. Dose-dependent uptake of 3'-deoxy-3'-[(18) F]fluorothymidine by the bowel after total-body irradiation. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 846-53. PMID 24915935 DOI: 10.1007/s11307-014-0755-y |
0.341 |
|
| 2014 |
Lehner S, Sussebach C, Todica A, Uebleis C, Brunner S, Bartenstein P, Van Kriekinge SD, Germano G, Hacker M. Influence of SPECT attenuation correction on the quantification of hibernating myocardium as derived from combined myocardial perfusion SPECT and ¹⁸F-FDG PET. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 21: 578-87. PMID 24633501 DOI: 10.1007/S12350-014-9882-8 |
0.439 |
|
| 2014 |
Jansen NL, Suchorska B, Wenter V, Eigenbrod S, Schmid-Tannwald C, Zwergal A, Niyazi M, Drexler M, Bartenstein P, Schnell O, Tonn JC, Thon N, Kreth FW, la Fougère C. Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 198-203. PMID 24379223 DOI: 10.2967/jnumed.113.122333 |
0.384 |
|
| 2014 |
Ewers M, Brendel M, Rizk-Jackson A, Rominger A, Bartenstein P, Schuff N, Weiner MW. Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects. Neuroimage. Clinical. 4: 45-52. PMID 24286024 DOI: 10.1016/J.Nicl.2013.10.018 |
0.639 |
|
| 2014 |
Brendel M, Delker A, Rötzer C, Böning G, Carlsen J, Cyran C, Mille E, Gildehaus FJ, Cumming P, Baumann K, Steiner H, Haass C, Herms J, Bartenstein P, Rominger A. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET. Neuroimage. 84: 843-53. PMID 24055703 DOI: 10.1016/J.Neuroimage.2013.09.017 |
0.632 |
|
| 2014 |
Jansen NL, Suchorska B, Wenter V, Schmid-Tannwald C, Niyazi M, Bartenstein P, Kreth F, Fougere CL, Tonn J. NI-41 * PROGNOSTIC SIGNIFICANCE OF DYNAMIC ANALYSIS OF 18FET-PET IN NEWLY DIAGNOSED HIGH GRADE GLIOMA Neuro-Oncology. 16: v147-v147. DOI: 10.1093/neuonc/nou264.39 |
0.575 |
|
| 2014 |
Becker-Bense S, Buchholz H, Baier B, Schreckenberger M, Bartenstein P, Dieterich M. Imaging the vestibular system after acute unilateral midbrain infarction – A combined lesion-behaviour mapping and FDG-PET study Klinische Neurophysiologie. 45. DOI: 10.1055/S-0034-1371189 |
0.327 |
|
| 2014 |
Araque Caballero MÁ, Brendel M, Delker A, Ren J, Rominger A, Bartenstein P, Weiner MW, Ewers M. IC-P-114: MAPPING 3-YEAR RATES OF DECLINE IN JOINTLY ASSESSED GRAY MATTER VOLUME AND FDG-PET IN AB+ NON-DEMENTED SUBJECTS Alzheimer's & Dementia. 10: P63-P64. DOI: 10.1016/j.jalz.2014.05.120 |
0.556 |
|
| 2014 |
Caballero MÁA, Brendel M, Delker A, Ren J, Rominger A, Bartenstein P, Weiner MW, Ewers M. O3-03-03: MAPPING 3-YEAR RATES OF DECLINE IN JOINTLY ASSESSED GRAY MATTER VOLUME AND FDG-PET IN Aβ+ NON-DEMENTED SUBJECTS Alzheimer's & Dementia. 10: P212-P212. DOI: 10.1016/J.Jalz.2014.04.282 |
0.566 |
|
| 2014 |
Rominger A, Brendel M, Rötzer C, Gildehaus F, Baumann K, Haass C, Steiner H, Herms J, Bartenstein P. Monitoring Of Long-Term Gamma Secretase Modulation Treatment In App-Swe Mice By Means Of [18F]-Florbetaben Pet Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.04.113 |
0.598 |
|
| 2013 |
Böning G, Todica A, Vai A, Lehner S, Xiong G, Mille E, Ilhan H, la Fougère C, Bartenstein P, Hacker M. Erroneous cardiac ECG-gated PET list-mode trigger events can be retrospectively identified and replaced by an offline reprocessing approach: first results in rodents. Physics in Medicine and Biology. 58: 7937-59. PMID 24165267 DOI: 10.1088/0031-9155/58/22/7937 |
0.313 |
|
| 2013 |
Rensch C, Jackson A, Lindner S, Salvamoser R, Samper V, Riese S, Bartenstein P, Wängler C, Wängler B. Microfluidics: a groundbreaking technology for PET tracer production? Molecules (Basel, Switzerland). 18: 7930-56. PMID 23884128 DOI: 10.3390/molecules18077930 |
0.315 |
|
| 2013 |
Uebleis C, Hellweger S, Laubender RP, Becker A, Sohn HY, Lehner S, Haug A, Bartenstein P, Cumming P, Van Kriekinge SD, Slomka PJ, Hacker M. The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction. The International Journal of Cardiovascular Imaging. 29: 1645-53. PMID 23744128 DOI: 10.1007/S10554-013-0254-2 |
0.338 |
|
| 2013 |
Fendler WP, Philippe Tiega DB, Ilhan H, Paprottka PM, Heinemann V, Jakobs TF, Bartenstein P, Hacker M, Haug AR. Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1202-8. PMID 23729697 DOI: 10.2967/jnumed.112.116426 |
0.381 |
|
| 2013 |
Rominger A, Brendel M, Burgold S, Keppler K, Baumann K, Xiong G, Mille E, Gildehaus FJ, Carlsen J, Schlichtiger J, Niedermoser S, Wängler B, Cumming P, Steiner H, Herms J, ... ... Bartenstein P, et al. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1127-34. PMID 23729696 DOI: 10.2967/Jnumed.112.114660 |
0.624 |
|
| 2013 |
Jansen NL, Suchorska B, Schwarz SB, Eigenbrod S, Lutz J, Graute V, Bartenstein P, Belka C, Kreth FW, la Fougère C. [18F]fluoroethyltyrosine-positron emission tomography-based therapy monitoring after stereotactic iodine-125 brachytherapy in patients with recurrent high-grade glioma. Molecular Imaging. 12: 137-47. PMID 23490440 |
0.378 |
|
| 2013 |
Rominger A, Cumming P, Xiong G, Koller G, Förster S, Zwergal A, Karamatskos E, Bartenstein P, La Fougère C, Pogarell O. Effects of acute detoxification of the herbal blend 'Spice Gold' on dopamine D2/3 receptor availability: a [18F]fallypride PET study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1606-10. PMID 23452563 DOI: 10.1016/J.Euroneuro.2013.01.009 |
0.312 |
|
| 2013 |
Becker-Bense S, Buchholz HG, Best C, Schreckenberger M, Bartenstein P, Dieterich M. Vestibular compensation in acute unilateral medullary infarction: FDG-PET study. Neurology. 80: 1103-9. PMID 23427323 DOI: 10.1212/WNL.0b013e31828868a6 |
0.311 |
|
| 2013 |
Todica A, Brunner S, Böning G, Lehner S, Nekolla SG, Wildgruber M, Übleis C, Wängler C, Sauter M, Klingel K, Cumming P, Bartenstein P, Schirrmacher R, Franz WM, Hacker M. [68Ga]-albumin-PET in the monitoring of left ventricular function in murine models of ischemic and dilated cardiomyopathy: comparison with cardiac MRI. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 441-9. PMID 23408338 DOI: 10.1007/S11307-013-0618-Y |
0.301 |
|
| 2013 |
Cumming P, Xiong G, la Fougère C, Rominger A, Bartenstein P, Buchholz HG, Piel M, Rösch F, Gründer G, Vernaleken I. Surrogate markers for cerebral blood flow correlate with [¹â¸F]-fallypride binding potential at dopamine D(2/3) receptors in human striatum. Synapse (New York, N.Y.). 67: 199-203. PMID 23239525 DOI: 10.1002/Syn.21630 |
0.333 |
|
| 2013 |
Mueller WP, Melzer HI, Schmid I, Coppenrath E, Bartenstein P, Pfluger T. The diagnostic value of 18F-FDG PET and MRI in paediatric histiocytosis. European Journal of Nuclear Medicine and Molecular Imaging. 40: 356-63. PMID 23096080 DOI: 10.1007/s00259-012-2278-6 |
0.449 |
|
| 2013 |
Jansen NL, Suchorska B, Schwarz SB, Eigenbrod S, Lutz J, Graute V, Bartenstein P, Belka C, Kreth FW, Fougère Cl. [
18
F]Fluoroethyltyrosine–Positron Emission Tomography-Based Therapy Monitoring after Stereotactic Iodine-125 Brachytherapy in Patients with Recurrent High-Grade Glioma Molecular Imaging. 12: 7290.2012.00027. DOI: 10.2310/7290.2012.00027 |
0.341 |
|
| 2013 |
Brendel M, Böning G, Delker A, Rötzer C, Gildehaus F, Baumann K, Steiner H, Haass C, Herms J, Bartenstein P, Rominger A. PET imaging using [18F]florbetaben in Alzheimer's disease mouse models Alzheimers & Dementia. 9: 29. DOI: 10.1016/J.Jalz.2013.05.041 |
0.647 |
|
| 2012 |
Xiong G, Paul C, Todica A, Hacker M, Bartenstein P, Böning G. Noninvasive image derived heart input function for CMRglc measurements in small animal slow infusion FDG PET studies. Physics in Medicine and Biology. 57: 8041-59. PMID 23160517 DOI: 10.1088/0031-9155/57/23/8041 |
0.326 |
|
| 2012 |
Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, Pöpperl G, Kretzschmar HA, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougère C, Thon N. Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas. Neuro-Oncology. 14: 1473-80. PMID 23090986 DOI: 10.1093/Neuonc/Nos259 |
0.329 |
|
| 2012 |
Haug AR, Cindea-Drimus R, Auernhammer CJ, Reincke M, Wängler B, Uebleis C, Schmidt GP, Göke B, Bartenstein P, Hacker M. The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1686-92. PMID 22984220 DOI: 10.2967/jnumed.111.101675 |
0.316 |
|
| 2012 |
Pfluger T, Melzer HI, Mueller WP, Coppenrath E, Bartenstein P, Albert MH, Schmid I. Diagnostic value of combined ¹â¸F-FDG PET/MRI for staging and restaging in paediatric oncology. European Journal of Nuclear Medicine and Molecular Imaging. 39: 1745-55. PMID 22926713 DOI: 10.1007/s00259-012-2228-3 |
0.46 |
|
| 2012 |
Graute V, Jansen N, Sohn HY, Becker A, Klein B, Schmid I, Greil S, Lehner S, Bartenstein P, Pfluger T, Hacker M. Diagnostic role of whole-body [18F]-FDG positron emission tomography in patients with symptoms suspicious for malignancy after heart transplantation. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 31: 958-66. PMID 22766023 DOI: 10.1016/j.healun.2012.05.011 |
0.301 |
|
| 2012 |
Holtmann MH, Uenzen M, Helisch A, Dahmen A, Mudter J, Goetz M, Schreckenberger M, Galle PR, Bartenstein P, Neurath MF. 18F-Fluorodeoxyglucose positron-emission tomography (PET) can be used to assess inflammation non-invasively in Crohn's disease. Digestive Diseases and Sciences. 57: 2658-68. PMID 22569824 DOI: 10.1007/s10620-012-2190-8 |
0.314 |
|
| 2012 |
Jansen NL, Graute V, Armbruster L, Suchorska B, Lutz J, Eigenbrod S, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougère C. MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? European Journal of Nuclear Medicine and Molecular Imaging. 39: 1021-9. PMID 22491781 DOI: 10.1007/S00259-012-2109-9 |
0.325 |
|
| 2012 |
Haug AR, Tiega Donfack BP, Trumm C, Zech CJ, Michl M, Laubender RP, Uebleis C, Bartenstein P, Heinemann V, Hacker M. 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 371-7. PMID 22331219 DOI: 10.2967/jnumed.111.096230 |
0.365 |
|
| 2012 |
Graute V, Jansen N, Ubleis C, Seitz M, Hartenbach M, Scherr MK, Thieme S, Cumming P, Klanke K, Tiling R, Bartenstein P, Hacker M. Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy. European Journal of Nuclear Medicine and Molecular Imaging. 39: 271-82. PMID 22086143 DOI: 10.1007/S00259-011-1970-2 |
0.331 |
|
| 2012 |
Rominger A, Cumming P, Xiong G, Koller G, Böning G, Wulff M, Zwergal A, Förster S, Reilhac A, Munk O, Soyka M, Wängler B, Bartenstein P, la Fougère C, Pogarell O. [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics. Addiction Biology. 17: 490-503. PMID 22023291 DOI: 10.1111/J.1369-1600.2011.00355.X |
0.337 |
|
| 2012 |
Förster S, Grimmer T, Miederer I, Henriksen G, Yousefi BH, Graner P, Wester HJ, Förstl H, Kurz A, Dickerson BC, Bartenstein P, Drzezga A. Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay. Biological Psychiatry. 71: 792-7. PMID 21679929 DOI: 10.1016/j.biopsych.2011.04.023 |
0.344 |
|
| 2012 |
Rominger A, Brendel M, Baumann K, Gildehaus F, Niedermoser S, Wängler B, Burgold S, Herms J, Cumming P, Steiner H, Haass C, Bartenstein P. Longitudinal imaging of cerebral beta-amyloid in APP-swe mice using [18F]florbetaben PET Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.411 |
0.612 |
|
| 2012 |
Rominger A, Brendel M, Baumann K, Gildehaus F, Niedermoser S, Wängler B, Burgold S, Herms J, Cumming P, Steiner H, Haass C, Bartenstein P. Longitudinal imaging of cerebral Aβ in APP-Swe mice using [18F]florbetaben PET Alzheimers & Dementia. 8: 11. DOI: 10.1016/J.Jalz.2012.05.033 |
0.644 |
|
| 2011 |
Langen KJ, Bartenstein P, Boecker H, Brust P, Coenen HH, Drzezga A, Grünwald F, Krause BJ, Kuwert T, Sabri O, Tatsch K, Weber WA, Schreckenberger M. [German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids]. Nuklearmedizin. Nuclear Medicine. 50: 167-73. PMID 21789338 DOI: 10.3413/nuk-2011041 |
0.325 |
|
| 2011 |
la Fougère C, Suchorska B, Bartenstein P, Kreth FW, Tonn JC. Molecular imaging of gliomas with PET: opportunities and limitations. Neuro-Oncology. 13: 806-19. PMID 21757446 DOI: 10.1093/neuonc/nor054 |
0.348 |
|
| 2011 |
Melzer HI, Coppenrath E, Schmid I, Albert MH, von Schweinitz D, Tudball C, Bartenstein P, Pfluger T. ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma. European Journal of Nuclear Medicine and Molecular Imaging. 38: 1648-58. PMID 21617976 DOI: 10.1007/s00259-011-1843-8 |
0.481 |
|
| 2011 |
Vernaleken I, Peters L, Raptis M, Lin R, Buchholz HG, Zhou Y, Winz O, Rösch F, Bartenstein P, Wong DF, Schäfer WM, Gründer G. The applicability of SRTM in [(18)F]fallypride PET investigations: impact of scan durations. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 31: 1958-66. PMID 21587267 DOI: 10.1038/jcbfm.2011.73 |
0.304 |
|
| 2011 |
Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C, Sabri O. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. The Lancet. Neurology. 10: 424-35. PMID 21481640 DOI: 10.1016/S1474-4422(11)70077-1 |
0.374 |
|
| 2011 |
Niyazi M, Geisler J, Siefert A, Schwarz SB, Ganswindt U, Garny S, Schnell O, Suchorska B, Kreth FW, Tonn JC, Bartenstein P, Fougre CL, Belka C. FET-PET for malignant glioma treatment planning Radiotherapy and Oncology. 99: 44-48. PMID 21458093 DOI: 10.1016/j.radonc.2011.03.001 |
0.325 |
|
| 2011 |
Haug AR, Bartenstein P. [Positron emission tomography (PET) and PET/CT for guiding therapy in oncology]. Deutsche Medizinische Wochenschrift (1946). 136: 468-72. PMID 21365523 DOI: 10.1055/s-0031-1274529 |
0.376 |
|
| 2011 |
Haug AR, Heinemann V, Bruns CJ, Hoffmann R, Jakobs T, Bartenstein P, Hacker M. 18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres. European Journal of Nuclear Medicine and Molecular Imaging. 38: 1037-45. PMID 21308371 DOI: 10.1007/s00259-011-1736-x |
0.391 |
|
| 2011 |
Pfluger T, Melzer HI, Schneider V, La Fougere C, Coppenrath E, Berking C, Bartenstein P, Weiss M. PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT. European Journal of Nuclear Medicine and Molecular Imaging. 38: 822-31. PMID 21210112 DOI: 10.1007/s00259-010-1702-z |
0.345 |
|
| 2011 |
Uebleis C, Ulbrich M, Tegtmeyer R, Schuessler F, Haserueck N, Siebermair J, Becker C, Nekolla S, Cumming P, Bartenstein P, Kääb S, Hacker M. Electrocardiogram-gated 18F-FDG PET/CT hybrid imaging in patients with unsatisfactory response to cardiac resynchronization therapy: initial clinical results. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 67-71. PMID 21149479 DOI: 10.2967/Jnumed.110.078709 |
0.385 |
|
| 2011 |
Schlenker B, Gratzke C, Tilki D, Tiling R, Bartenstein P, Siegert S, Stief C, Seitz M. 836 A PROSPECTIVE SINGLE-CENTER STUDY TO EVALUATE 18F-FLUORODEOXYGLUCOSE PET/CT IN STAGING PATIENTS WITH PENILE SQUAMOUS CELL CARCINOMA Journal of Urology. 185. DOI: 10.1016/J.JURO.2011.02.656 |
0.394 |
|
| 2010 |
Yakushev I, Bartenstein P, Siessmeier T, Hiemke C, Scheurich A, Lotz J, Fellgiebel A, Müller MJ. Cerebrospinal fluid tau protein levels and 18F-fluorodeoxyglucose positron emission tomography in the differential diagnosis of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 30: 245-53. PMID 20847555 DOI: 10.1159/000320206 |
0.369 |
|
| 2010 |
Rominger A, Mille E, Zhang S, Böning G, Förster S, Nowak S, Gildehaus FJ, Wängler B, Bartenstein P, Cumming P. Validation of the octamouse for simultaneous 18F-fallypride small-animal PET recordings from 8 mice. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1576-83. PMID 20847158 DOI: 10.2967/Jnumed.110.078451 |
0.343 |
|
| 2010 |
Bartmann H, Fuest C, la Fougere C, Xiong G, Just T, Schlichtiger J, Winter P, Böning G, Wängler B, Pekcec A, Soerensen J, Bartenstein P, Cumming P, Potschka H. Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy. Epilepsia. 51: 1780-90. PMID 20633036 DOI: 10.1111/J.1528-1167.2010.02671.X |
0.302 |
|
| 2010 |
Fottner C, Helisch A, Anlauf M, Rossmann H, Musholt TJ, Kreft A, Schadmand-Fischer S, Bartenstein P, Lackner KJ, Klöppel G, Schreckenberger M, Weber MM. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression. The Journal of Clinical Endocrinology and Metabolism. 95: 2800-10. PMID 20371665 DOI: 10.1210/jc.2009-2352 |
0.408 |
|
| 2010 |
la Fougère C, Pöpperl G, Levin J, Wängler B, Böning G, Uebleis C, Cumming P, Bartenstein P, Bötzel K, Tatsch K. The value of the dopamine D2/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 581-7. PMID 20237026 DOI: 10.2967/Jnumed.109.071811 |
0.328 |
|
| 2010 |
Rominger A, Rist C, Nikolaou K, Reiser MF, Bartenstein P, Hacker M, Saam T. [PET/CT imaging of atherosclerotic blood vessel alterations]. Der Radiologe. 50: 355-65. PMID 20221580 DOI: 10.1007/s00117-009-1969-x |
0.378 |
|
| 2010 |
Gründer G, Vernaleken I, Bartenstein P. [Use of PET and SPECT in psychiatry]. Der Nervenarzt. 81: 97-107; quiz 108. PMID 20066394 DOI: 10.1007/s00115-009-2830-1 |
0.32 |
|
| 2010 |
la Fougère C, Zwergal A, Rominger A, Förster S, Fesl G, Dieterich M, Brandt T, Strupp M, Bartenstein P, Jahn K. Real versus imagined locomotion: a [18F]-FDG PET-fMRI comparison. Neuroimage. 50: 1589-98. PMID 20034578 DOI: 10.1016/j.neuroimage.2009.12.060 |
0.323 |
|
| 2010 |
Helisch A, Thews O, Buchholz HG, Tillmanns J, Kronfeld A, Schreiber LM, Schreckenberger M, Bartenstein P. Small animal tumour imaging with MRI and the ECAT EXACT scanner: application of partial volume correction and comparison with microPET data. Nuclear Medicine Communications. 31: 294-300. PMID 20023592 DOI: 10.1097/MNM.0b013e328334fc2a |
0.366 |
|
| 2010 |
la Fougère C, Böning G, Bartmann H, Wängler B, Nowak S, Just T, Wagner E, Winter P, Rominger A, Förster S, Gildehaus FJ, Rosa-Neto P, Minuzzi L, Bartenstein P, Potschka H, et al. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar. Neuroimage. 49: 1406-15. PMID 19796699 DOI: 10.1016/J.Neuroimage.2009.09.048 |
0.318 |
|
| 2010 |
Zwergal A, La Fougere C, Bartenstein P, Dieterich M, Brandt T, Strupp M, Jahn K. Imagination versus reality: locomotion in fMRI and PET Klinische Neurophysiologie. 41. DOI: 10.1055/s-0030-1251009 |
0.402 |
|
| 2010 |
Schlenker B, Gratzke C, Reich O, Tilki D, Schneede P, Tiling R, Bartenstein P, Siegert S, Stief C, Seitz M. 553 DETECTION OF INGUINAL LYMPH NODE INVOLVEM IN PENILE SQUAMOUS CELL CARCINOMA BY 18F-FLUORODEOXYGLUCOSE PET/CT European Urology Supplements. 9: 188-189. DOI: 10.1016/S1569-9056(10)60544-1 |
0.327 |
|
| 2010 |
Zwergal A, La Fougere C, Bartenstein P, Dieterich M, Brandt T, Jahn K. 012 IMAGINED VERSUS REAL LOCOMOTION: AN INTRAINDIVIDUAL FMRI-PET COMPARISON Parkinsonism & Related Disorders. 16: S3-S4. DOI: 10.1016/S1353-8020(10)70013-4 |
0.389 |
|
| 2010 |
Vernaleken I, Peters L, Robert L, Rösch F, Bartenstein P, Schaefer WM, Gründer G. Equilibrium in [18F]fallypride PET Neuroimage. 52: S160. DOI: 10.1016/j.neuroimage.2010.04.130 |
0.444 |
|
| 2009 |
Gehler B, Paulsen F, Oksüz MO, Hauser TK, Eschmann SM, Bares R, Pfannenberg C, Bamberg M, Bartenstein P, Belka C, Ganswindt U. [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning. Radiation Oncology (London, England). 4: 56. PMID 19922642 DOI: 10.1186/1748-717X-4-56 |
0.321 |
|
| 2009 |
Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, NÃ¥gren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. European Journal of Nuclear Medicine and Molecular Imaging. 36: 2103-10. PMID 19838705 DOI: 10.1007/S00259-009-1264-0 |
0.439 |
|
| 2009 |
Rominger A, Saam T, Wolpers S, Cyran CC, Schmidt M, Foerster S, Nikolaou K, Reiser MF, Bartenstein P, Hacker M. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease Journal of Nuclear Medicine. 50: 1611-1620. PMID 19759117 DOI: 10.2967/jnumed.109.065151 |
0.34 |
|
| 2009 |
la Fougère C, Rominger A, Förster S, Geisler J, Bartenstein P. PET and SPECT in epilepsy: a critical review. Epilepsy & Behavior : E&B. 15: 50-5. PMID 19236949 DOI: 10.1016/j.yebeh.2009.02.025 |
0.308 |
|
| 2009 |
Haug A, Auernhammer CJ, Wängler B, Tiling R, Schmidt G, Göke B, Bartenstein P, Pöpperl G. Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. 36: 765-70. PMID 19137293 DOI: 10.1007/s00259-008-1030-8 |
0.389 |
|
| 2009 |
Wängler B, Quandt G, Iovkova L, Schirrmacher E, Wängler C, Boening G, Hacker M, Schmoeckel M, Jurkschat K, Bartenstein P, Schirrmacher R. Kit-like 18F-labeling of proteins: synthesis of 4-(di-tert-butyl[18F]fluorosilyl)benzenethiol (Si[18F]FA-SH) labeled rat serum albumin for blood pool imaging with PET. Bioconjugate Chemistry. 20: 317-21. PMID 19132825 DOI: 10.1021/Bc800413G |
0.393 |
|
| 2009 |
Barthel H, Gertz H, Dresel S, Heuser I, Bartenstein P, Buerger K, Reininger C, Hiemeyer F, Sabri O. FP43-TH-03 [18 F]BAY 94–9172 positron emission tomography in the detection/exclusion of cerebral amyloid beta: an open-label, multicentre study in patients with probable Alzheimer's disease compared with healthy volunteers Journal of the Neurological Sciences. 285: S126. DOI: 10.1016/S0022-510X(09)70497-6 |
0.326 |
|
| 2009 |
Barthel H, Gertz H, Dresel S, Heuser I, Bartenstein P, Buerger K, Reininger C, Kunz M, Sabri O. O1‐05‐06: Efficacy of [
18
F]BAY94‐9172 Positron Emission Tomography in the Detection/Exclusion of Cerebral Amyloid Beta in Patients with Probable Alzheimer's Disease Compared with Healthy Volunteers: An Open‐label, Global, Multicentre Study Alzheimer's & Dementia. 5. DOI: 10.1016/j.jalz.2009.12.002 |
0.332 |
|
| 2008 |
Yakushev I, Landvogt C, Buchholz HG, Fellgiebel A, Hammers A, Scheurich A, Schmidtmann I, Gerhard A, Schreckenberger M, Bartenstein P. Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Research. 164: 143-53. PMID 18930634 DOI: 10.1016/j.pscychresns.2007.11.004 |
0.401 |
|
| 2008 |
Pfluger T, Schneider V, Hacker M, Bröckel N, Morhard D, Hundt W, Bartenstein P, Becker C, Tiling R, la Fougère C. Restaging of patients with lymphoma Nuklearmedizin. 47: 37-42. DOI: 10.3413/NUKMED-0114 |
0.36 |
|
| 2007 |
Kumakura Y, Cumming P, Vernaleken I, Buchholz HG, Siessmeier T, Heinz A, Kienast T, Bartenstein P, Gründer G. Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8080-7. PMID 17652599 DOI: 10.1523/Jneurosci.0805-07.2007 |
0.344 |
|
| 2007 |
Fellgiebel A, Scheurich A, Bartenstein P, Müller MJ. FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment. Psychiatry Research. 155: 167-71. PMID 17531450 DOI: 10.1016/j.pscychresns.2006.12.002 |
0.305 |
|
| 2007 |
Fottner C, Helisch A, Anlauf M, Klöppel G, Düber C, Bartenstein P, Schreckenberger M, Weber M. The expression of the Vesicular Monoamine Transporter type 1 (VMAT-1) is necessary for functional imaging of pheochromocytomas with [123J]-Metaiodobenzylguanidine (MIBG) scintigraphy – Superiority of 6-[18F]- Fluorodopamin Positron Emission Tomography (DOPA-PET) for the localization of VMAT-1 negative tumors Experimental and Clinical Endocrinology & Diabetes. 115. DOI: 10.1055/s-2007-972256 |
0.409 |
|
| 2007 |
Best C, Bense S, Buchholz H, Schlindwein P, Brandt T, Bartenstein P, Dieterich M. P13. Compensation processes for central vestibular dysfunction in patients with acute medullary infarctions (FDG-PET study) Clinical Neurophysiology. 118: 2820. DOI: 10.1016/j.clinph.2007.09.042 |
0.338 |
|
| 2006 |
Schirrmacher R, Bradtmöller G, Schirrmacher E, Thews O, Tillmanns J, Siessmeier T, Buchholz HG, Bartenstein P, Wängler B, Niemeyer CM, Jurkschat K. 18F-labeling of peptides by means of an organosilicon-based fluoride acceptor. Angewandte Chemie (International Ed. in English). 45: 6047-50. PMID 16888726 DOI: 10.1002/Anie.200600795 |
0.363 |
|
| 2006 |
Teipel SJ, Drzezga A, Bartenstein P, Möller HJ, Schwaiger M, Hampel H. Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial. Psychopharmacology. 187: 86-94. PMID 16767418 DOI: 10.1007/s00213-006-0408-1 |
0.38 |
|
| 2006 |
Bense S, Best C, Buchholz HG, Wiener V, Schreckenberger M, Bartenstein P, Dieterich M. 18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus. Neuroreport. 17: 599-603. PMID 16603919 DOI: 10.1097/00001756-200604240-00009 |
0.367 |
|
| 2006 |
Kunkel M, Helisch A, Reichert TE, Jeong JH, Buchholz HG, Benz P, Bartenstein P, Wagner W, Whiteside TL. Clinical and prognostic value of [(18)F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapy. Oral Oncology. 42: 297-305. PMID 16316775 DOI: 10.1016/J.Oraloncology.2005.08.004 |
0.417 |
|
| 2006 |
Bense S, Buchholz H, Best C, Schlindwein P, Brandt T, Bartenstein P, Dieterich M. Compensation for central vestibular dysfunction in patients with acute medullary infarctions (FDG-PET study) Aktuelle Neurologie. 33. DOI: 10.1055/S-2006-953053 |
0.361 |
|
| 2006 |
Fottner C, Helisch A, Schreckenberger M, Bartenstein P, Weber M. Superiority of 6-[18F]- Fluorodopamin Positron Emission Tomography (DOPA-PET) versus [123J]-Metaiodobenzylguanidine (MIBG) scintigraphy in the localization of extraadrenal or multifocal pheochromocytomas and paragangliomas Experimental and Clinical Endocrinology & Diabetes. 114. DOI: 10.1055/S-2006-932888 |
0.435 |
|
| 2006 |
Hansen T, Brochhausen C, Kneist W, Oberholzer K, Junginger T, Schreckenberger M, Bartenstein P, Buchmann I. FDG-PET in the initial staging of squamous cell oesophageal carcinoma Nuklearmedizin. 45: 235-241. DOI: 10.1055/S-0038-1625108 |
0.339 |
|
| 2006 |
Vernaleken I, Kumakura Y, Buchholz H, Siessmeier T, Bartenstein P, Cumming P, Gründer G. Relationship between prefrontal cognitive functions and dopaminergic transmission: A [18F]-fluoro-l-DOPA PET study Neuroimage. 31: T172. DOI: 10.1016/j.neuroimage.2006.04.155 |
0.318 |
|
| 2005 |
Tonn P, Bartenstein P, Dahmen N. [Lithium intoxication mimics Alzheimer's disease in PET and clinical findings]. Der Nervenarzt. 76: 613-6. PMID 15241600 DOI: 10.1007/s00115-004-1758-8 |
0.36 |
|
| 2005 |
Vernaleken I, Kumakura Y, Buchholz H, Siessmeier T, Bartenstein P, Cumming P, Gründer G. Prefrontal cognitive performance of healthy subjects positively correlates with 18F-FDOPA uptake in positron emission tomography Pharmacopsychiatry. 38. DOI: 10.1055/S-2005-918861 |
0.319 |
|
| 2005 |
Kahaly G, Egle U, Bartenstein P, Dittmar M, Drecker S, Weber M, Schreckenberger M. Positron emission tomography (PET) study on the neuronal correlates of hyperthyroidism- associated mood changes Experimental and Clinical Endocrinology & Diabetes. 113. DOI: 10.1055/S-2005-862893 |
0.319 |
|
| 2005 |
Kunkel M, Helisch A, Reichert T, Jeong J, Benz P, Bartenstein P, Wagner W, Whiteside T. The value of [18F]FDG-PET for diagnosis and prognosis in recurrent oral squamous cell carcinoma International Journal of Oral and Maxillofacial Surgery. 34: 15. DOI: 10.1016/S0901-5027(05)80917-8 |
0.378 |
|
| 2004 |
Schreckenberger M, Hägele S, Siessmeier T, Buchholz HG, Armbrust-Henrich H, Rösch F, Gründer G, Bartenstein P, Vogt T. The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism. European Journal of Nuclear Medicine and Molecular Imaging. 31: 1128-35. PMID 15042325 DOI: 10.1007/s00259-004-1465-5 |
0.39 |
|
| 2004 |
Bartenstein P. [PET in neuroscience: dopaminergic, GABA/benzodiazepine, and opiate system]. Nuklearmedizin. Nuclear Medicine. 43: 33-42. PMID 14978539 DOI: 10.1267/NUKL04010033 |
0.329 |
|
| 2004 |
Kunkel M, Helisch A, Reichert TE, Bartenstein P, Wagner W. Surveillance of basaloid oral squamous cell carcinoma: the value of [18F]FDG-PET. Oral Oncology. 40: 56-62. PMID 14662416 DOI: 10.1016/S1368-8375(03)00135-0 |
0.471 |
|
| 2004 |
Schlindwein P, Birklein F, Dieterich M, Buchholz H, Bartenstein P. Cerebral Correlates of the Activation of the Cardiovascular Autonomic Nervous System – An FDG-PET Study Klinische Neurophysiologie. 35. DOI: 10.1055/S-2004-832155 |
0.377 |
|
| 2004 |
Bense S, Schlindwein P, Prange K, Buchholz H, Brandt T, Bartenstein P, Dieterich M. Contralateral Activation of the Vestibular Cortex in Acute Vestibular Neuritis (FDG-PET Study) Klinische Neurophysiologie. 35. DOI: 10.1055/S-2004-831931 |
0.339 |
|
| 2004 |
Gründer G, Schreckenberger M, Dielentheis T, Lochmann M, Mann K, Lange-Asschenfeld C, Siessmeier T, Buchholz H, Amberg R, Bartenstein P. Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies Pharmacopsychiatry. 36. DOI: 10.1055/S-2003-825347 |
0.383 |
|
| 2003 |
Kunkel M, Förster GJ, Reichert TE, Jeong JH, Benz P, Bartenstein P, Wagner W, Whiteside TL. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management. Cancer. 98: 2257-65. PMID 14601097 DOI: 10.1002/Cncr.11763 |
0.449 |
|
| 2003 |
Kneist W, Schreckenberger M, Bartenstein P, Grünwald F, Oberholzer K, Junginger T. Positron emission tomography for staging esophageal cancer: does it lead to a different therapeutic approach? World Journal of Surgery. 27: 1105-12. PMID 12917769 DOI: 10.1007/s00268-003-6921-z |
0.406 |
|
| 2003 |
Gründer G, Siessmeier T, Piel M, Vernaleken I, Buchholz HG, Zhou Y, Hiemke C, Wong DF, Rösch F, Bartenstein P. Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 44: 109-16. PMID 12515884 |
0.373 |
|
| 2003 |
Kunkel M, Förster GJ, Reichert TE, Kutzner J, Benz P, Bartenstein P, Wagner W. Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma. Oral Oncology. 39: 170-7. PMID 12509971 DOI: 10.1016/S1368-8375(02)00087-8 |
0.432 |
|
| 2003 |
Döbert N, Rieker O, Kneist W, Mose S, Teising A, Junginger T, Böttcher HD, Bartenstein P, Grünwald F, Menzel C. 18F-Deoxyglucose PET for the staging of oesophageal cancer Nuklearmedizin. 42: 90-93. DOI: 10.1055/S-0038-1625303 |
0.306 |
|
| 2002 |
Förster GJ, Laumann C, Nickel O, Kann P, Rieker O, Bartenstein P. SPET/CT image co-registration in the abdomen with a simple and cost-effective tool. European Journal of Nuclear Medicine and Molecular Imaging. 30: 32-9. PMID 12483407 DOI: 10.1007/s00259-002-1013-0 |
0.31 |
|
| 2002 |
Neurath MF, Vehling D, Schunk K, Holtmann M, Brockmann H, Helisch A, Orth T, Schreckenberger M, Galle PR, Bartenstein P. Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. The American Journal of Gastroenterology. 97: 1978-85. PMID 12190164 DOI: 10.1111/j.1572-0241.2002.05836.x |
0.373 |
|
| 2002 |
Gründer G, Siessmeier T, Lange-Asschenfeldt C, Vernaleken I, Buchholz HG, Stoeter P, Drzezga A, Lüddens H, Rösch F, Bartenstein P. [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors. European Journal of Nuclear Medicine. 28: 1463-70. PMID 11685488 DOI: 10.1007/s002590100594 |
0.401 |
|
| 2002 |
Hausteiner C, Drzezga A, Bartenstein P, Schwaiger M, Förstl H, Zilker T, Bornschein S. PET in patients with clear-cut multiple chemical sensitivity (MCS) Nuklearmedizin. 41: 233-239. DOI: 10.1055/S-0038-1625294 |
0.343 |
|
| 2000 |
Neurath MF, Vehling M, Schunk K, Brockmann H, Orth T, Galle PR, Bartenstein P. FDG-PET: A novel non-invasive method to detect affected bowel segments in Crohn's disease? Gastroenterology. 118: A320. DOI: 10.1016/S0016-5085(00)83369-7 |
0.313 |
|
| 1999 |
Grünwald F, Herholz K, Kuwert T, Tatsch K, Sabri O, Weiller C, Bartenstein P. Rolle der Positronen-Emissions-Tomographie (PET) und Single-Photon-Emissions-Tomographie (SPECT) bei der sogenannten »Multiple Chemical Sensitivity« (MCS) Nuklearmedizin. 38: 297-301. DOI: 10.1055/S-0038-1632224 |
0.343 |
|
| 1998 |
Pietrini P, Teipel SJ, Bartenstein P, Rapoport SI, Möller HJ, Hampel H. PET and the effects of aging and neurodegeneration on brain function: basic principles. Drug News & Perspectives. 11: 161-5. PMID 15616616 DOI: 10.1358/Dnp.1998.11.3.863652 |
0.413 |
|
| 1998 |
Gross MW, Weber WA, Feldmann HJ, Bartenstein P, Schwaiger M, Molls M. The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas. International Journal of Radiation Oncology, Biology, Physics. 41: 989-95. PMID 9719107 DOI: 10.1016/S0360-3016(98)00183-7 |
0.395 |
|
| 1997 |
Arnold W, Bartenstein P, Oestreicher E, Römer W, Schwaiger M. Focal metabolic activation in the predominant left auditory cortex in patients suffering from tinnitus: a PET study with [18F]deoxyglucose. Orl; Journal For Oto-Rhino-Laryngology and Its Related Specialties. 58: 195-9. PMID 8883104 DOI: 10.1159/000276835 |
0.38 |
|
| 1996 |
Kötter H, Mager T, Möller H, Ulbricht D, Pfluger T, Dresel S, Bartenstein P, Hampel H. Structural and functional imaging using MRI, SPECT and PET improves the diagnostical accuracy in patients with frontal lobe dementia syndromes Neuroimage. 3: S493. DOI: 10.1016/S1053-8119(96)80495-2 |
0.316 |
|
| 1996 |
Gross M, Weber W, Feldmann H, Bartenstein P, Schwaiger M, Molls M. 550IMT-spect and FDG-pet in the 3-D radiation treatment planning for gliomas Radiotherapy and Oncology. 40: S141. DOI: 10.1016/S0167-8140(96)80559-7 |
0.312 |
|
| Show low-probability matches. |